Focal epilepsy

partial epilepsy: A seizure caused by a localized disorder.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — G40.0, G40.1, G40.2 Hospital discharge: ICD-9 — 345[45] Hospital discharge: ICD-8 — 3453 Cause of death: ICD-10 — G40.0, G40.1, G40.2 Cause of death: ICD-9 — 345[45] Cause of death: ICD-8 — 3453 2 out of 7 registries used, show all original rules.	11335
4. Check minimum number of events None	11335
5. Include endpoints None	11335
6. Filter based on genotype QC (FinnGen only)	10135

Control definitions (FinnGen only)

Control exclude: G6_EPLEPSY

Extra metadata

First used in FinnGen datafreeze: DF3
Parent code in ICD-10: G40

NAME	FE
CONTROL_EXCLUDE	G6_EPLEPSY
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	G40[0-2]
HD_ICD_9	345[45]
HD_ICD_8	3453
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	G40[0-2]
COD_ICD_9	345[45]
COD_ICD_8	3453
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Focal epilepsy based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	93716	43658	49305
Only index persons	78280	37622	40658
Unadjusted period prevalence (%)
Whole population	1.31	1.25	1.38
Only index persons	1.47	1.38	1.55
Median age at first event (years)
Whole population	51.09	50.54	51.41
Only index persons	49.13	48.68	49.54

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	10135	5078	5057
Unadjusted period prevalence (%)	2.06	1.80	2.32
Median age at first event (years)	54.34	49.47	59.22

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
10440: Matched controls
104342

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

AA1BM

NOMESCO Finland

MRI examination of brain with 3 Tesla magnet

10.6

310.9

343

332

K90

ICPC

Stroke/cerebrovascular accident

5.5

308.5

619

1180

R55

ICD-10 Finland

Syncope and collapse

2.9

308.5

1684

6478

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

8.5

307.7

968

1237

C79.30

ICD-10 Finland

Secondary malignant tumor of the cerebrum

12.5

307.7

341

280

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

3.4

307.7

3077

11514

G40.6

ICD-10 Finland

Grand mal seizures, unspecified (with or without petit mal)

1851.7

307.7

342

G40.1

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures

+∞

307.7

503

G40

ICD-10 Finland

Epilepsy

1095.2

307.7

1168

N03AX18

ATC

lacosamide; systemic

1152.5

307.7

1311

N03AX14

ATC

levetiracetam; systemic

251.6

307.7

4241

283

L01AX03

ATC

temozolomide; systemic

44.5

307.7

549

130

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

+∞

307.7

8792

N03AF02

ATC

oxcarbazepine; oral

184.0

307.7

4489

426

N03AF01

ATC

carbamazepine; oral, rectal

20.3

307.7

2578

1662

G40.21

ICD-10 Finland

Partial epileptic seizure with cloudiness and automatism

3601.0

307.7

695

G41.9

ICD-10 Finland

Status epilepticus, unspecified

117.8

307.7

537

N88

ICPC

Epilepsy

955.6

307.7

876

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

5.0

307.7

1703

3881

G40.20

ICD-10 Finland

Complex partial seizures with only alteration of consciousness

16384.0

307.7

1810

N05BA09

ATC

clobazam; oral

416.5

307.7

913

C71.20

ICD-10 Finland

Malignant tumor in temporal lobe without histology

103.4

307.7

173

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

+∞

307.7

3873

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

16384.0

307.7

3953

ZXC95

NOMESCO Finland

Use of surgical navigator

11.3

307.7

400

366

G40.10

ICD-10 Finland

Simple partial seizures

14649.8

307.7

1297

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

3.6

307.7

1750

5574

7803A

ICD-9 Finland

General symptoms, Convulsions

14.3

307.7

331

238

G40.12

ICD-10 Finland

Simple partial seizures with secondary generalization

+∞

307.7

1484

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

3.6

307.7

1758

5568

183

Kela drug reimbursment

Lamotrigin and topiramate

+∞

307.7

1409

G40.19

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures

5875.6

307.7

1079

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

3.4

307.7

1383

4466

N05BA01

ATC

diazepam; systemic, rectal

3.9

307.7

2305

7087

N03AX09

ATC

lamotrigine; oral

9.5

307.7

1630

2003

N03AX23

ATC

brivaracetam; systemic

+∞

307.7

416

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

7.4

307.7

2541

4320

G40.09

ICD-10 Finland

Other or unspecified partial (focal) idiopathic epilepsy or epileptic syndrome with local onset

6603.6

307.7

632

R56.8

ICD-10 Finland

Other and unspecified convulsions

42.4

307.7

4058

1543

I69.1

ICD-10 Finland

Sequelae of intracerebral haemorrhage

15.8

307.7

489

323

3454A

ICD-9 Finland

Epilepsy, Partial epilepsy, with impairment of consciousness[EPILEPSIA GENERALISATA SECUNDARIA]

+∞

307.7

341

AAG50

NOMESCO Finland

Stereotactic intracranial radiotherapy

28.0

307.7

294

108

N03AB02

ATC

phenytoin; systemic

63.6

307.7

817

139

XA800

NOMESCO Finland

Neuropsychological investigation

7.7

307.7

1301

1906

D43.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Brain, supratentorial

39.0

307.7

427

114

G40.00

ICD-10 Finland

Benign childhood epilepsy with centrotemporal EEG spikes

4425.2

307.7

435

N05CD08

ATC

midazolam; nasal, systemic

11.5

307.7

822

771

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

10.8

307.7

646

635

AA1AD

NOMESCO Finland

CT of head and brain

5.0

307.7

5562

19366

N03AG01

ATC

valproic acid; systemic, rectal

28.6

307.7

3785

2033

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.7

307.7

2459

10792

G40.39

ICD-10 Finland

Other or unspecified generalized epileptic syndromes with atonic, clonic, myoclonic or tonic-clonic seizures

4490.3

307.7

441

G41.0

ICD-10 Finland

Grand mal status epilepticus

152.5

307.7

180

AAB10

NOMESCO Finland

Partial excision of intracranial lesion

41.2

307.7

730

190

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

+∞

307.7

4390

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

4.9

307.7

2112

5100

C71.11

ICD-10 Finland

Malignant tumor of frontal lobe grade II glioma

160.8

307.7

174

N03AX15

ATC

zonisamide; oral

71.7

307.7

259

XA400

NOMESCO Finland

EEG

23.9

307.7

298

128

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

4.8

307.7

891

1981

G40.2

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

+∞

307.7

1223

G40.11

ICD-10 Finland

Simple partial epileptic seizure that develops into a complex partial seizure

+∞

307.7

450

G40.9

ICD-10 Finland

Epilepsy, unspecified

2110.7

307.7

4470

N03AE01

ATC

clonazepam; systemic

4.2

307.7

1027

2613

G40.89

ICD-10 Finland

Other epilepsy

5442.8

307.7

528

C71.10

ICD-10 Finland

Malignant tumor in frontal lobe without histology

90.8

307.7

257

AAB00

NOMESCO Finland

Extirpation of intracranial lesion

17.2

307.7

559

343

N03AX11

ATC

topiramate; oral

8.8

307.7

697

845

D32.00

ICD-10 Finland

Benign tumor of the meninges on the outer surface of the cerebrum

9.6

307.7

388

420

G41.2

ICD-10 Finland

Complex partial status epilepticus

106.2

305.1

157

I69.0

ICD-10 Finland

Sequelae of subarachnoid haemorrhage

12.5

301.7

299

246

O99.3

ICD-10 Finland

Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium

8.5

301.5

396

483

Z2445

NOMESCO Finland

Psychologist

4.4

297.2

794

1923

N03AX22

ATC

perampanel; oral

2739.7

287.5

277

H02AB02

ATC

dexamethasone; systemic

2.9

287.1

1583

6107

T90.5

ICD-10 Finland

Sequelae of intracranial injury

9.7

283.2

333

352

I61.9

ICD-10 Finland

Intracerebral haemorrhage, unspecified

7.7

277.0

393

525

N07

ICPC

Convulsion/seizure

39.0

276.4

169

AA5BD

NOMESCO Finland

CT of cerebral ischaemia

5.9

274.0

511

909

C71.2

ICD-10 Finland

Malignant neoplasm: Temporal lobe

116.5

270.6

138

R41.0

ICD-10 Finland

Disorientation, unspecified

4.9

268.8

615

1313

C71.1

ICD-10 Finland

Malignant neoplasm: Frontal lobe

72.4

264.7

143

78020

ICD-8 Finland

Certain symptoms referable to nervous system and special senses, Convulsions

11.3

262.7

278

253

34599

ICD-8 Finland

Epilepsy, Other and unspecified

+∞

252.0

241

AA1BD

NOMESCO Finland

Extensive CT of head and brain

5.7

252.0

485

888

I61.1

ICD-10 Finland

Intracerebral haemorrhage in hemisphere, cortical

13.7

248.2

232

173

C71.13

ICD-10 Finland

Malignant tumor of frontal lobe grade IV glioma

73.6

243.0

131

C71.23

ICD-10 Finland

Malignant tumor of temporal lobe grade IV glioma

76.8

240.7

129

C71.90

ICD-10 Finland

Malignant tumor in unspecified localization in the brain without histology

29.8

236.1

156

S06.5

ICD-10 Finland

Traumatic subdural haemorrhage

4.5

234.7

601

1404

G40.4

ICD-10 Finland

Other generalized epilepsy and epileptic syndromes

2207.1

234.0

226

9530/0-C70.0

ICD-O-3

Meningioma, NOS, of cerebral meninges

13.1

231.4

222

173

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.7

227.2

1349

5372

R4150

NOMESCO Finland

Neuropsychological rehabilitation

11.5

224.5

234

208

H53.4

ICD-10 Finland

Visual field defects

5.6

223.5

431

790

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.3

222.8

2086

10254

3459X

ICD-9 Finland

Epilepsy, unspecified

+∞

220.5

211

R47.0

ICD-10 Finland

Dysphasia and aphasia

9.2

218.6

268

299

34532

ICD-8 Finland

Epilepsy, Partialis (focalis) generalisata

+∞

215.3

206

TAB00

NOMESCO Finland

Lumbar puncture

3.7

214.6

720

2046

3451A

ICD-9 Finland

Epilepsy, Generalised convulsive epilepsy

+∞

212.1

203

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

5.8

210.1

396

710

3454B

ICD-9 Finland

Epilepsy, Partial epilepsy, with impairment of consciousness[TEMPORAALIEPILEPTINEN POISSAOLOKOHTAUS]

+∞

207.9

199

G40.3

ICD-10 Finland

Generalized idiopathic epilepsy and epileptic syndromes

+∞

207.9

199

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.9

207.0

3660

22716

PA2BD

NOMESCO Finland

Extensive CT angiography of brain

6.6

205.5

334

517

I63.3

ICD-10 Finland

Cerebral infarction due to thrombosis of cerebral arteries

3.9

204.5

634

1705

N18

ICPC

Paralysis/weakness

5.5

201.1

402

761

YX8VG

NOMESCO Finland

Stereotactic MRI exmaination with high intensity magnet for dose design of radiotherapy

22.8

197.9

144

A28

ICPC

Limited function/disability NOS

2.1

195.6

2177

11410

34530

ICD-8 Finland

Epilepsy, Psychomotorica

+∞

193.3

185

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.0

191.9

3095

18529

AA1DM

NOMESCO Finland

Very extensive MRI examination of brain with 3 Tesla magnet

10.2

188.4

213

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

6.2

187.9

329

549

G40.30

ICD-10 Finland

Benign myoclonic eplilepsy in infancy

+∞

185.9

178

AAG00

NOMESCO Finland

Stereotactic intracranial biopsy

33.2

179.9

115

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

3.0

179.1

883

3168

YX8BD

NOMESCO Finland

Stereotactic extensive CT examination for dose design of radiotherapy

15.0

178.3

158

107

N05AX08

ATC

risperidone; systemic

2.6

177.5

1152

4766

S06.3

ICD-10 Finland

Focal brain injury

6.8

176.2

280

423

N03AG04

ATC

vigabatrin; oral

+∞

172.3

165

G40.0

ICD-10 Finland

Localization-related (focal)(partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset

1771.1

172.2

167

130

Kela drug reimbursment

Malignant tumour

2.6

171.8

1152

4838

I61.0

ICD-10 Finland

Intracerebral haemorrhage in hemisphere, subcortical

6.0

171.2

309

531

YA1AD

NOMESCO Finland

CT examination of head and neck for dose design of radiotherapy

8.0

169.9

231

293

ZXC40

NOMESCO Finland

Use of ultrasound

10.2

167.7

189

188

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

2.6

166.9

1038

4200

WX892

NOMESCO Finland

Monitored bed care

2.6

158.1

1007

4118

D32.02

ICD-10 Finland

Benign tumor of the meninges at the base of the brain

8.4

157.5

207

252

D43.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Central nervous system, unspecified

20.2

156.9

120

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.6

154.7

961

3881

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

3.4

154.4

579

1763

R4120

NOMESCO Finland

Occupational therapy

2.7

153.4

880

3414

F10.31

ICD-10 Finland

Withdrawal symptoms caused by alcohol with seizures

8.7

153.2

195

228

AAC00

NOMESCO Finland

Ligature of intracranial aneurysm

7.5

152.4

220

299

R1230

NOMESCO Finland

Neuropsychological evaluation of need and possibilities to rehabilitation

6.7

151.3

243

371

I60.1

ICD-10 Finland

Subarachnoid haemorrhage from middle cerebral artery

12.2

149.0

149

124

S06.0

ICD-10 Finland

Concussion

2.2

148.5

1376

6644

F02.89*G40.9

ICD-10 Finland

Dementia in epilepsy

+∞

147.2

141

XF400

NOMESCO Finland

ECG with 12 standard connections

2.0

140.3

1808

9877

N06AB04

ATC

citalopram; systemic

1.9

138.9

2198

12864

AA1AG

NOMESCO Finland

Short MRI examination of brain with median intensity magnet

5.3

138.9

283

544

N03AF04

ATC

eslicarbazepine; oral

+∞

138.8

133

C71.30

ICD-10 Finland

Malignant tumor in parietal lobe without histology

50.4

138.6

D43.2

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Brain, unspecified

22.7

135.9

34510

ICD-8 Finland

Epilepsy, """"Grand mal""""

+∞

135.7

130

WX882

NOMESCO Finland

High dependency care

3.5

134.0

489

1462

AAK00

NOMESCO Finland

Cranioplasty

36.3

133.1

T36

ICD-10 Finland

Poisoning by systemic antibiotics

3.1

133.1

577

1917

D32.01

ICD-10 Finland

Benign tumor of meninges on interhemispheric surface

11.9

133.0

135

115

N05AH04

ATC

quetiapine; oral

1.9

132.0

1982

11382

R51.80

ICD-10 Finland

Headache

2.0

131.7

1786

9911

181

Kela drug reimbursment

Retigabine and vigabatrin

+∞

131.5

126

W19

ICD-10 Finland

Unspecified fall

2.2

130.4

1236

6003

F05.9

ICD-10 Finland

Delirium, unspecified

4.2

129.7

354

865

C71.99

ICD-10 Finland

Malignant tumor in unspecified localization in the brain other or unspecified histology

35.5

129.0

9440/3-C71.9

ICD-O-3

Glioblastoma, NOS, of brain, NOS

47.2

128.1

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.6

128.1

4910

36636

L28

ICPC

Limited function/disability (L)

1.9

127.9

2073

12189

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

3.2

126.2

514

1645

C71.12

ICD-10 Finland

Malignant tumor of frontal lobe grade III glioma

219.2

126.0

130

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.0

124.6

1476

7797

R53

ICD-10 Finland

Malaise and fatigue

1.7

124.1

2785

18022

G41.8

ICD-10 Finland

Other status epilepticus

47.6

121.5

ADB00

NOMESCO Finland

Implantation of vagus nerve stimulating device

1171.4

119.0

116

I60.9

ICD-10 Finland

Subarachnoid haemorrhage, unspecified

5.5

118.7

233

433

K91

ICPC

Cerebrovascular disease

5.2

116.1

244

482

AAF00

NOMESCO Finland

Ventriculostomy

9.1

116.0

142

158

9440/3-C71.2

ICD-O-3

Glioblastoma, NOS, of temporal lobe

64.4

115.9

A06AD11

ATC

lactulose; oral

1.9

114.8

1621

9080

N05BA04

ATC

oxazepam; oral

1.7

114.5

2694

17597

F70.0

ICD-10 Finland

Mild mental retardation, With the statement of no, or minimal, impairment of behaviour

11.1

113.3

120

109

N74

ICPC

Malignant neoplasm nervous system

35.7

113.3

SPAT1229

SPAT

Assessment of need for aid

2.4

112.9

876

3903

N05AH03

ATC

olanzapine; systemic

2.5

111.8

761

3195

ZX050

NOMESCO Finland

Stereotactic radiotherapy

6.8

111.8

175

260

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

2.4

111.5

851

3763

R40.2

ICD-10 Finland

Coma, unspecified

6.8

111.0

175

262

N28

ICPC

Limited function/disability (N)

4.4

110.3

283

659

R42

ICD-10 Finland

Dizziness and giddiness

1.7

110.0

2428

15555

D32.9

ICD-10 Finland

Benign neoplasm: Meninges, unspecified

11.0

110.0

117

107

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

3.7

109.8

351

960

SPAT1216

SPAT

Assessment of functional ability

1.9

108.8

1631

9303

Z2446

NOMESCO Finland

Social worker

2.4

106.9

823

3652

WX872

NOMESCO Finland

Intensive care

2.6

106.6

630

2470

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

2.5

106.1

699

2889

G91.0

ICD-10 Finland

Communicating hydrocephalus

9.4

104.4

125

135

Z51.5

ICD-10 Finland

Palliative care

2.2

103.9

1005

4899

TPH04

NOMESCO Finland

Cathetrisation of vein

1.7

103.4

2335

15017

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.0

102.8

1232

6506

Q28.2

ICD-10 Finland

Arteriovenous malformation of cerebral vessels

14.6

101.3

YA1BD

NOMESCO Finland

Extensive CT examination of head and neck for dose design of radiotherapy

6.3

101.1

170

272

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

2.3

100.8

783

3485

N03AX25

ATC

cenobamate; oral

+∞

100.1

R4130

NOMESCO Finland

Speech therapy

3.3

99.3

379

1164

PA2CC

NOMESCO Finland

Cerebral very extensive angiography with X-ray

7.0

99.1

152

221

WX730

NOMESCO Finland

Conventional respirator

4.4

99.0

250

575

C71.33

ICD-10 Finland

Malignant tumor of parietal lobe grade IV glioma

56.3

99.0

PA6AD

NOMESCO Finland

CT of neck arteries

2.9

98.9

489

1746

R56.0

ICD-10 Finland

Febrile convulsions

9.0

98.0

121

136

S01.0

ICD-10 Finland

Open wound of scalp

2.2

97.9

936

4538

9440/3-C71.1

ICD-O-3

Glioblastoma, NOS, of frontal lobe

51.1

97.2

N29

ICPC

Neurological sympt/complt other

3.8

97.1

298

792

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.8

96.8

1581

9236

C71.21

ICD-10 Finland

Malignant tumor of temporal lobe grade II glioma

201.8

96.5

100

N02AA05

ATC

oxycodone; systemic

1.8

96.3

1885

11621

S06.2

ICD-10 Finland

Diffuse brain injury

5.7

96.2

180

320

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.6

95.8

580

2299

PA2BC

NOMESCO Finland

Cerebral extensive angiography with X-ray

5.8

95.4

177

312

I63.4

ICD-10 Finland

Cerebral infarction due to embolism of cerebral arteries

3.2

95.4

398

1290

C71.3

ICD-10 Finland

Malignant neoplasm: Parietal lobe

50.2

95.1

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

3.1

93.0

413

1388

ZXE20

NOMESCO Finland

More than three and less than five hours

1.9

91.8

1389

7912

TKC20

NOMESCO Finland

Catheterisation of bladder

2.3

91.5

780

3607

3069, ,

Kela drug reimbursment

+∞

90.7

AAF05

NOMESCO Finland

Ventriculoperitoneal shunt

5.1

90.4

192

383

N05AA02

ATC

levomepromazine; systemic

2.8

90.0

468

1716

1541, ,

Kela drug reimbursment

+∞

89.7

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

2.2

89.5

781

3646

N76

ICPC

Neoplasm nervous system unspecified

26.7

88.8

G80.2

ICD-10 Finland

Spastic hemiplegic cerebral palsy

24.4

88.8

34539

ICD-8 Finland

Epilepsy, Partialis (focalis) NUD

+∞

88.6

AEA50

NOMESCO Finland

Adjustment of implanted neurostimulator

10.0

88.6

101

102

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.8

88.5

1408

8143

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.8

88.2

1634

9891

N19

ICPC

Speech disorder

4.0

87.5

249

627

A03FA01

ATC

metoclopramide; systemic, rectal

1.7

87.4

2146

14026

C71.00

ICD-10 Finland

Malignant tumor of the cerebrum except lobes and ventricles without histology

29.1

87.0

A04AA02

ATC

granisetron; systemic, transdermal

2.3

86.8

678

3020

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

2.1

85.9

888

4428

XCK00

NOMESCO Finland

Perimetry

2.3

85.5

683

3071

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

2.4

85.3

649

2857

SPAT1234

SPAT

Support of social functional capacity

2.4

84.0

605

2599

AAF20

NOMESCO Finland

Revision of shunt of ventricle of brain

9.1

83.6

102

113

AA5PD

NOMESCO Finland

CT examination of brain pefusion

5.4

83.4

165

309

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.9

83.2

1199

6712

F79.0

ICD-10 Finland

Unspecified mental retardation, with the statement of no, or minimal, impairment of behaviour

12.1

83.0

A86

ICD-10 Finland

Unspecified viral encephalitis

8.4

82.0

107

129

N05CF01

ATC

zopiclone; oral

1.5

81.9

3055

22006

I67.1

ICD-10 Finland

Cerebral aneurysm, nonruptured

3.8

81.5

251

669

ZXD05

NOMESCO Finland

Urgent procedure

1.5

79.7

2954

21222

SPAT1254

SPAT

Administration of medicine

1.7

79.6

1565

9610

PA2AD

NOMESCO Finland

CT angiography of brain

5.5

79.0

153

281

H47.2

ICD-10 Finland

Optic atrophy

8.4

78.7

102

122

AA5DR

NOMESCO Finland

Brain metabolism PET with CT

16.0

78.6

YA1VG

NOMESCO Finland

MRI examination of head and neck with high intesity magnet for dose design of radiotherapy

7.7

78.3

110

145

3454X

ICD-9 Finland

Epilepsy, Partial epilepsy, with impairment of consciousness[ALII DISTURBATIONES CONSCIENTAE EPILEPTICI]

+∞

78.2

R1260

NOMESCO Finland

Evaluation of communicative skills

3.9

77.3

228

589

G40.36

ICD-10 Finland

Juvenile myoclonic epilepsy [impulsive petit mal]

+∞

77.1

XX3DW

NOMESCO Finland

Time consuming IT work

1.9

77.1

1070

5908

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

2.4

76.9

533

2249

G41.1

ICD-10 Finland

Petit mal status epilepticus

45.2

75.9

C71.22

ICD-10 Finland

Malignant tumor of temporal lobe grade III glioma

196.3

75.2

C03CA01

ATC

furosemide; systemic

1.5

74.0

2912

21125

D32.0

ICD-10 Finland

Benign neoplasm: Cerebral meninges

9.2

73.8

G81.9

ICD-10 Finland

Hemiplegia, unspecified

4.9

73.3

164

342

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

3.6

72.4

241

677

X59

ICD-10 Finland

Exposure to unspecified factor

1.6

72.3

1954

13005

WF002

NOMESCO Finland

Radical radiotherapy

2.2

72.2

610

2804

N05CD07

ATC

temazepam; oral

1.8

72.1

1104

6284

M03BX01

ATC

baclofen; systemic

3.5

71.9

247

709

Q28.3

ICD-10 Finland

Other malformations of cerebral vessels

9.0

71.8

F80.1

ICD-10 Finland

Expressive language disorder

4.6

71.7

170

372

G04.9

ICD-10 Finland

Encephalitis, myelitis and encephalomyelitis, unspecified

10.5

70.8

G40.7

ICD-10 Finland

Petit mal, unspecified, without grand mal seizures

183.7

70.1

N05BA06

ATC

lorazepam; systemic, sublingual

2.3

69.6

543

2414

N99

ICPC

Neurological disease other

4.2

69.5

187

452

9530/0-C70.9

ICD-O-3

Meningioma, NOS, of meninges, NOS

12.4

69.1

G40.51

ICD-10 Finland

Epileptic seizures related to alcohol

682.6

69.1

N06AX11

ATC

mirtazapine; oral

1.5

69.1

3235

24255

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.6

68.5

1775

11677

SPAT1301

SPAT

No procedures

1.5

67.3

3005

22289

P20

ICPC

Memory disturbance

1.7

67.0

1355

8355

Z3231

NOMESCO Finland

Registered nurse

1.5

66.9

2679

19431

P85

ICPC

Mental retardation

9.9

65.6

R50.9

ICD-10 Finland

Fever, unspecified

1.6

65.2

1589

10283

R11

ICD-10 Finland

Nausea and vomiting

1.9

65.2

942

5258

AAJ20

NOMESCO Finland

Excision of epileptic focus

+∞

64.6

R46.8

ICD-10 Finland

Other symptoms and signs involving appearance and behaviour

18.0

64.5

N06AB10

ATC

escitalopram; oral

1.6

64.4

1937

13179

D33.00

ICD-10 Finland

Medial pilosytic astrocytoma of the cerebrum

15.8

64.0

AAD05

NOMESCO Finland

Evacuation of acute subdural haematoma

7.7

63.1

115

ZXE30

NOMESCO Finland

More than five and less than seven hours

2.3

62.8

510

2304

F71.0

ICD-10 Finland

Moderate mental retardation, with the statement of no, or minimal, impairment of behaviour

23.8

62.8

N05AD01

ATC

haloperidol; systemic

2.7

62.4

352

1345

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.6

61.7

1528

9914

4380A

ICD-9 Finland

Late effects of cerebrovascular disease[SEQUELAE MORBI CEREBROVASCULARIS]

8.0

61.7

104

34533

ICD-8 Finland

Epilepsy, Partialis (focalis) alia

+∞

61.5

I69.2

ICD-10 Finland

Sequelae of other nontraumatic intracranial haemorrhage

12.3

61.5

PA7BD

NOMESCO Finland

CT angiography of neck and brain

3.6

61.2

205

579

Z01.8

ICD-10 Finland

Other specified special examinations

1.5

61.1

2190

15472

PA7CD

NOMESCO Finland

CT angiography of neck and brain, extensive

4.4

60.8

152

347

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

2.9

60.7

285

988

G40.80

ICD-10 Finland

Epilepsy with continuous EEG spike-waves during slow wave sleep

+∞

60.5

AAA10

NOMESCO Finland

Biopsy through craniotomy

18.5

60.3

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.9

60.2

825

4523

R41.3

ICD-10 Finland

Other amnesia

2.7

59.9

334

1269

3453A

ICD-9 Finland

Epilepsy, Grand mal status

591.3

59.8

OAB43, ,

SPAT

0.6

59.8

1459

21631

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.7

59.7

1311

8245

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.8

59.1

912

5190

F29

ICD-10 Finland

Unspecified nonorganic psychosis

2.5

58.9

392

1622

ZXM40

NOMESCO Finland

Use of fluorescent substance

16.2

58.9

N03AX12

ATC

[U] gabapentin; oral

1.6

58.7

1470

9554

G40.59

ICD-10 Finland

Other special epileptic syndromes

581.2

58.7

S06.6

ICD-10 Finland

Traumatic subarachnoid haemorrhage

4.5

58.5

144

325

D32.04

ICD-10 Finland

Secondary or multiple benign tumor of the meninges above the exam

21.0

58.4

AWC00

NOMESCO Finland

Reoperation of nervous system because of deep wound infection in the nervous system

23.4

58.2

R1250

NOMESCO Finland

Evaluation of functional capability

2.8

57.8

292

1053

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.1

57.4

596

2966

3455A

ICD-9 Finland

Epilepsy, Partial epilepsy, without mention of impairment of consciousness

+∞

57.3

Z3226

NOMESCO Finland

Physiotherapist

1.6

57.3

1716

11631

G91.1

ICD-10 Finland

Obstructive hydrocephalus

7.7

57.2

105

G45.1

ICD-10 Finland

Carotid artery syndrome (hemispheric)

2.5

57.1

376

1548

AAB30

NOMESCO Finland

Evacuation of spontaneous intracranial haematoma

14.1

56.9

I63.0

ICD-10 Finland

Cerebral infarction due to thrombosis of precerebral arteries

3.7

56.3

182

502

H02AB09

ATC

hydrocortisone; systemic

2.8

56.2

298

1103

C71.19

ICD-10 Finland

Malignant tumor of frontal lobe other or unspecified histology

79.3

56.0

N03AA02

ATC

phenobarbital; systemic

21.1

55.8

R90.8

ICD-10 Finland

Other abnormal findings on diagnostic imaging of central nervous system

4.1

55.8

155

384

RS222, ,

NOMESCO Finland

3.8

55.7

169

446

G80.1

ICD-10 Finland

Spastic diplegic cerebral palsy

17.1

55.7

AAA27

NOMESCO Finland

Insertion of intracerebral pressure monitoring device

17.1

55.7

2161

FHL

Neck ligation, big brain

9.3

55.3

F83

ICD-10 Finland

Mixed specific developmental disorders

5.0

55.2

118

237

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.0

55.2

645

3349

D43.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Brain, infratentorial

12.0

54.7

WX408

NOMESCO Finland

General anesthesy, balanced

1.5

54.7

2400

17611

N03AG06

ATC

tiagabine; oral

540.7

54.6

2152

FHL

Extraction, big brain

15.1

54.4

4300A

ICD-9 Finland

Subarachnoid haemorrhage[HAEMORRHAGIA SUBARACHNOID. POST ANEURYSMA SACCULARE]

8.5

54.4

F10.09

ICD-10 Finland

Alcohol intoxication UNS

3.0

54.1

241

811

C71.29

ICD-10 Finland

Malignant tumor in temporal lobe other or unspecified histology

86.2

53.9

AAD15

NOMESCO Finland

Evacuation of traumatic intracerebral haematoma

19.2

53.6

AAD10

NOMESCO Finland

Evacuation of chronic subdural haematoma

3.8

53.4

163

432

S06.4

ICD-10 Finland

Epidural haemorrhage

12.1

53.0

A04

ICPC

Weakness/tiredness general

1.6

52.7

1585

10734

R90.0

ICD-10 Finland

Intracranial space-occupying lesion

14.2

52.7

SPAT1231

SPAT

Assessment of adjustments needed in living environment

3.2

52.7

216

693

B01AC04

ATC

clopidogrel; oral

1.6

52.6

1515

10161

B01AA03

ATC

warfarin; systemic

1.5

52.3

1753

12159

G81.1

ICD-10 Finland

Spastic hemiplegia

13.3

51.9

AA5FG

NOMESCO Finland

Functional MRI examination of brain with high intensity magnet

138.2

51.8

N02BE01

ATC

paracetamol; systemic, rectal

1.5

51.7

8761

80795

R4110

NOMESCO Finland

Physiotherapy

1.4

51.3

2571

19305

34598

ICD-8 Finland

Epilepsy, Alia definita

+∞

51.1

D32.03

ICD-10 Finland

Benign meningioma in ventricles

13.9

51.0

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

3.0

50.9

232

791

ZXE10

NOMESCO Finland

More than one and less than three hours

1.4

50.2

3211

25150

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.2

50.1

461

2189

F70.9

ICD-10 Finland

Mild mental retardation, Without mention of impairment of behaviour

13.5

50.1

G40.8

ICD-10 Finland

Other epilepsy

+∞

50.0

ZXY02

NOMESCO Finland

Neuropsychologist

5.7

49.4

163

A02BC02

ATC

pantoprazole; systemic

1.4

48.6

6406

56143

N05AF03

ATC

chlorprothixene; systemic

2.7

48.4

261

975

G80.9

ICD-10 Finland

Cerebral palsy, unspecified

19.1

48.3

G72.8

ICD-10 Finland

Other specified myopathies

3.3

48.2

188

585

G40.50

ICD-10 Finland

Epilepsia partialis continua [Kozhevnikof]

+∞

47.9

N03AD01

ATC

ethosuximide; oral

+∞

47.9

F44.5

ICD-10 Finland

Dissociative convulsions

77.6

47.9

WF003

NOMESCO Finland

Adjuvant radiotherapy

2.4

47.7

336

1427

I60.0

ICD-10 Finland

Subarachnoid haemorrhage from carotid siphon and bifurcation

8.0

47.7

AWB00

NOMESCO Finland

Reoperation for superficial infection in surgery of the nervous system

9.7

47.4

Z02.4

ICD-10 Finland

Examination for driving licence

0.6

47.2

1376

19800

AAJ99

NOMESCO Finland

Other operation for epilepsy

+∞

46.9

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.4

46.7

2898

22522

SPAT1245

SPAT

Provision of support and information to patient’s family members

2.1

46.6

432

2057

SPAT1240

SPAT

Therapeutic discussion

1.7

46.2

957

5907

F70.1

ICD-10 Finland

Mild mental retardation, Significant impairment of behaviour requiring attention or treatment

10.9

45.9

G06.0

ICD-10 Finland

Intracranial abscess and granuloma

14.0

45.8

I69.8

ICD-10 Finland

Sequelae of other and unspecified cerebrovascular diseases

5.9

45.8

140

R25.1

ICD-10 Finland

Tremor, unspecified

2.4

45.6

332

1430

OAA67, ,

SPAT

0.5

45.5

619

10761

F10.20

ICD-10 Finland

Alcohol dependence currently independent

2.9

45.1

219

774

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.9

45.0

591

3189

9400/3-C71.1

ICD-O-3

Astrocytoma, NOS, of frontal lobe

230.9

45.0

N03AX16

ATC

[U] pregabalin

1.5

44.9

1995

14592

G91.9

ICD-10 Finland

Hydrocephalus, unspecified

6.2

44.8

123

34519

ICD-8 Finland

Epilepsy, Generalisata convulsiva NUD

+∞

44.8

XX1XW

NOMESCO Finland

Extensive written report from radiologist

2.7

44.7

238

883

G05.1*B00.4

ICD-10 Finland

Herpesviral meningoencephalitis

18.0

44.6

I63.1

ICD-10 Finland

Cerebral infarction due to embolism of precerebral arteries

3.6

44.6

150

425

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.5

44.4

1767

12649

F10.25

ICD-10 Finland

Alcohol dependence continuous use

3.0

44.3

193

642

F79.9

ICD-10 Finland

Unspecified mental retardation, without mention of impairment of behaviour

15.0

44.2

WYA20

NOMESCO Finland

Home visit

2.8

44.1

217

772

F07.9

ICD-10 Finland

Unspecified organic personality and behavioural disorder due to brain disease, damage and dysfunction

14.3

44.1

I67.6

ICD-10 Finland

Nonpyogenic thrombosis of intracranial venous system

9.5

44.1

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.1

43.9

409

1951

I63.8

ICD-10 Finland

Other cerebral infarction

4.0

43.7

126

321

R25.2

ICD-10 Finland

Cramp and spasm

2.5

42.8

264

1054

N05AX12

ATC

aripiprazole; systemic

2.2

42.7

392

1859

R47.8

ICD-10 Finland

Other and unspecified speech disturbances

4.0

42.7

123

313

G40.35

ICD-10 Finland

Juvenile absence epilepsy

+∞

42.7

I60.8

ICD-10 Finland

Other subarachnoid haemorrhage

9.8

42.7

WF049

NOMESCO Finland

Radiotherapy of metastasis

2.2

42.6

354

1613

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

4.0

42.3

119

298

ZSA00

NOMESCO Finland

Procedure related to previous procedure classified in chapter A

6.8

42.3

R5110, ,

SPAT

1.7

41.8

779

4669

C71.31

ICD-10 Finland

Malignant tumor of the parietal lobe grand II glioma

147.2

41.8

B01AC07

ATC

dipyridamole; systemic

2.1

41.7

415

2030

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.1

41.7

400

1930

F03

ICD-10 Finland

Unspecified dementia

2.1

41.4

411

2010

N06AX16

ATC

venlafaxine; oral

1.5

41.0

1225

8250

S22.3

ICD-10 Finland

Fracture of rib

1.8

40.7

680

3951

GBB00

NOMESCO Finland

Tracheostomy

3.6

40.6

134

375

F05.8

ICD-10 Finland

Other delirium

4.3

40.5

105

247

N05AB03

ATC

perphenazine; systemic, rectal

2.3

40.4

325

1462

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

3.8

40.3

124

331

I61.8

ICD-10 Finland

Other intracerebral haemorrhage

7.7

40.3

F10.41

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol with seizures

8.4

40.2

XX1FW

NOMESCO Finland

Written report from MRI examination performed elsewhere

16.2

40.0

G04.8

ICD-10 Finland

Other encephalitis, myelitis and encephalomyelitis

16.2

40.0

PA2AC

NOMESCO Finland

Cerebral angiography with X-ray

5.8

39.9

124

G83.8

ICD-10 Finland

Other specified paralytic syndromes

13.7

39.9

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

2.8

39.7

199

716

H53.2

ICD-10 Finland

Diplopia

2.3

39.7

322

1454

C79.39

ICD-10 Finland

Secondary malignant tumor of the meninges, ventricle or other part of the brain

9.1

39.4

N05AH02

ATC

clozapine; systemic

2.9

39.3

188

659

A29

ICPC

General symptom/complaint other

1.5

39.3

1257

8585

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.4

39.2

2432

18804

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

3.0

39.1

177

602

A04AA01

ATC

ondansetron; systemic, rectal

1.7

39.0

741

4461

ZXD35

NOMESCO Finland

Usual procedure

2.2

38.8

318

1441

9450/3-C71.1

ICD-O-3

Oligodendroglioma, NOS, of frontal lobe

137.1

38.7

I61

ICD-10 Finland

Intracerebral haemorrhage

11.5

38.6

34500

ICD-8 Finland

Epilepsy, """"Petit mal""""

+∞

38.5

WZC00

NOMESCO Finland

Treatment plan or consultation

1.3

38.4

3456

28267

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

3.0

38.3

167

556

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.2

38.2

348

1646

Y86

ICD-10 Finland

Sequelae of other accidents

6.0

37.9

113

U04

ICPC

Incontinence urine

1.9

37.8

536

2961

G93.0

ICD-10 Finland

Cerebral cysts

5.8

37.7

117

S42.2

ICD-10 Finland

Fracture of upper end of humerus

2.0

37.7

438

2267

I95.1

ICD-10 Finland

Orthostatic hypotension

2.1

37.6

384

1897

F06.9

ICD-10 Finland

Unspecified mental disorder due to brain damage and dysfunction and to physical disease

7.0

37.6

Q04.8

ICD-10 Finland

Other specified congenital malformations of brain

50.2

37.5

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

3.9

37.5

110

284

AAJ15

NOMESCO Finland

Hippocampectomy

+∞

37.5

3450A

ICD-9 Finland

Epilepsy, Generalised nonconvulsive epilepsy

+∞

37.5

ZY010

NOMESCO Finland

Hospital outpatient

1.9

37.4

502

2725

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.0

37.4

422

2161

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.6

37.1

1040

6895

F10.06

ICD-10 Finland

Alcohol-related acute intoxication with seizures

12.0

36.7

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.7

36.7

771

4767

AEA00

NOMESCO Finland

Replacement of impulse generator of stimulation device in the nervous system

5.1

36.6

153

N06AB06

ATC

sertraline; oral

1.6

36.5

1005

6634

F20.9

ICD-10 Finland

Schizophrenia, unspecified

2.7

36.5

203

771

TPH07

NOMESCO Finland

Cathetrisation of artery

1.6

36.5

1032

6855

SPAT1053

SPAT

Memory test

1.5

36.5

1182

8088

I62.0

ICD-10 Finland

Nontraumatic subdural haemorrhage

4.2

36.5

233

T85.0

ICD-10 Finland

Mechanical complication of ventricular intracranial (communicating) shunt

9.8

36.5

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.4

36.5

1737

12814

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.7

36.5

665

3958

AAC40

NOMESCO Finland

Extirpation of intracranial arterio-venous malformation

53.9

36.3

113

Kela drug reimbursment

Anxiety disorders associated with mental retardation

9.0

35.9

9400/3-C71.9

ICD-O-3

Astrocytoma, NOS, of brain, NOS

185.5

35.8

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

1.9

35.7

491

2686

D32.07

ICD-10 Finland

Secondary or multiple benign tumor of the meninges below the exam

13.8

35.6

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

2.0

35.6

425

2220

Y0209

ICD-8 Finland

Examination of the nervous system and sensory organs, Nervous system

4.6

35.5

184

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.5

35.4

1269

8866

SPAT1252

SPAT

Overall medication plan or its review

1.8

35.3

587

3404

P72

ICPC

Schizophrenia

2.7

35.1

191

717

F06.8

ICD-10 Finland

Other specified mental disorders due to brain damage and dysfunction and to physical disease

11.6

35.1

N30.0

ICD-10 Finland

Acute cystitis

1.4

35.1

1480

10671

AA7AA

NOMESCO Finland

Liquor cerebri shunt X-ray examinatin without contrast

6.2

35.0

C71.32

ICD-10 Finland

Malignant tumor of parietal lobe grade III glioma

348.3

34.9

E87.6

ICD-10 Finland

Hypokalaemia

2.1

34.8

326

1559

S00.0

ICD-10 Finland

Superficial injury of scalp

2.4

34.8

252

1084

3039X

ICD-9 Finland

Alcohol dependence syndrome, Other and unspecified alcohol dependence

3.2

34.8

135

420

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

3.0

34.5

149

494

G40.33

ICD-10 Finland

Juvenile absence epilepsy

+∞

34.4

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

2.6

34.3

204

801

Z75.5

ICD-10 Finland

Holiday relief care

4.0

33.9

246

JN4AD

NOMESCO Finland

Body CT examination

1.5

33.9

1014

6816

N04AA02

ATC

biperiden; systemic

2.7

33.9

181

674

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

1.9

33.7

466

2555

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.5

33.7

1169

8108

B01AB05

ATC

enoxaparin; parenteral

1.3

33.1

2668

21374

G45.4

ICD-10 Finland

Transient global amnesia

2.5

32.9

213

871

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

2.0

32.9

354

1783

H03AA01

ATC

levothyroxine sodium; systemic

1.4

32.9

1878

14265

F01.9

ICD-10 Finland

Vascular dementia, unspecified

2.9

32.8

154

535

SPAT1224

SPAT

Implementation of speech therapy rehabilitation plan

2.8

32.7

161

574

A41.9

ICD-10 Finland

Sepsis, unspecified

2.0

32.6

342

1706

F10.24

ICD-10 Finland

Alcohol depence active use

2.8

32.5

161

576

C71.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of brain

48.9

32.5

WC105

NOMESCO Finland

Simple cytostatic therapy of local tumor recidive

5.4

32.4

120

E950A

ICD-9 Finland

Suicide and self-inflicted poisoning by solid or liquid substances

3.7

32.4

102

277

AAA35

NOMESCO Finland

Insertion of subdural electrodes

+∞

32.3

R40.0

ICD-10 Finland

Somnolence

5.6

32.3

110

ZYC01

NOMESCO Finland

Remote contact by phone

1.7

32.2

568

3349

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.3

32.1

2520

20099

P29

ICPC

Psychological sympt/compl other

1.6

32.0

690

4292

WX704

NOMESCO Finland

Intubation

1.6

31.7

728

4600

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.7

31.7

658

4053

C08CA01

ATC

amlodipine; oral

1.3

31.6

3298

27348

G45.0

ICD-10 Finland

Vertebro-basilar artery syndrome

2.3

31.6

244

1080

N07BB01

ATC

disulfiram; oral

2.0

31.5

374

1949

AAF25

NOMESCO Finland

Removal of shunt of ventricle of brain

7.8

31.4

F10.49

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without information about seizures

4.5

31.4

170

Q85.1

ICD-10 Finland

Tuberous sclerosis

60.2

31.0

N05CD02

ATC

nitrazepam; oral

2.8

30.9

155

559

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.6

30.8

779

5037

V700A

ICD-9 Finland

General medical examination, Routine general medical examination at a health care facility

2.3

30.6

228

994

C02AC05

ATC

moxonidine; oral

1.9

30.6

400

2154

I63.5

ICD-10 Finland

Cerebral infarction due to unspecified occlusion or stenosis of cerebral arteries

2.8

30.5

149

529

RS221, ,

NOMESCO Finland

2.8

30.3

155

564

R47.1

ICD-10 Finland

Dysarthria and anarthria

3.4

30.3

108

319

P99

ICPC

Psychological disorders other

2.1

30.3

284

1360

G40.52

ICD-10 Finland

Epileptic seizures related to drugs

+∞

30.2

G40.01

ICD-10 Finland

Pediatric epilepsy with occipital EEG paroxysms

+∞

30.2

Z50.5

ICD-10 Finland

Speech therapy

2.7

30.2

164

616

RL140, ,

NOMESCO Finland

6.9

30.0

S02.11

ICD-10 Finland

Fracture of base of skull, open

5.9

29.8

-, ,

ICD-10 Finland

2.4

29.8

212

906

7819X

ICD-9 Finland

Symptoms involving nervous and musculoskeletal systems, Other symptoms involving nervous and musculoskeletal systems[SYMPTOMATA ALIA SYSTEMATIS NERVORUM ET MUSCULOSCEL]

3.7

29.5

258

G31.2

ICD-10 Finland

Degeneration of nervous system due to alcohol

4.1

29.4

196

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.5

29.3

1123

7929

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

1.9

29.2

381

2051

43090

ICD-8 Finland

Subarachnoid haemorrhage, Postaneurysma sacculare, hypertonia non indicata

9.2

29.1

WX110

NOMESCO Finland

Infiltration anesthesia

1.3

28.9

6738

61394

Z02.7

ICD-10 Finland

Issue of medical certificate

1.6

28.8

673

4268

C71.01

ICD-10 Finland

Malignant tumor of cerebellum except lobes and ventricles grade II glioma

150.3

28.6

R4120, ,

SPAT

2.8

28.6

144

520

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

3.4

28.6

104

311

PA3AC

NOMESCO Finland

Carotis angiography with X-ray

5.2

28.5

112

ZX095

NOMESCO Finland

Combined chemoradiotherapy

4.1

28.5

192

D21

ICPC

Swallowing problem

2.7

28.4

158

601

F06.32

ICD-10 Finland

Organic depression

6.8

28.4

R2120

NOMESCO Finland

Counselling and guidance concerning rehabilitation services and social security

3.4

28.3

289

I63.2

ICD-10 Finland

Cerebral infarction due to unspecified occlusion or stenosis of precerebral arteries

3.4

28.1

101

300

AAF15

NOMESCO Finland

Ventriculoatrial shunt

6.5

28.0

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.7

27.9

588

3632

C07AA05

ATC

propranolol; systemic

1.4

27.9

1644

12514

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.3

27.9

2638

21517

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.6

27.8

627

3940

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

2.2

27.8

236

1087

JN4BD

NOMESCO Finland

Extensive body CT

1.5

27.8

842

5667

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

1.8

27.7

446

2560

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.7

27.5

497

2947

N80

ICPC

Head injury other

2.2

27.5

221

995

OAB48, ,

SPAT

0.6

27.4

696

10451

9694A

ICD-9 Finland

Poisoning by psychotropic agents, Benzodiazepine-based tranquillisers

4.2

27.3

168

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.5

27.2

886

6052

E87.0

ICD-10 Finland

Hyperosmolality and hypernatraemia

5.1

27.2

113

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

2.5

27.2

172

697

3458X

ICD-9 Finland

Epilepsy, Other forms of epilepsy

+∞

27.1

Z00.0

ICD-10 Finland

General medical examination

1.4

27.0

1697

13046

OAA80, ,

SPAT

0.5

27.0

338

6065

N05AD03

ATC

melperone; systemic

3.0

27.0

122

416

AA9CW, ,

NOMESCO Finland

8.4

26.9

N06AX03

ATC

mianserin; oral

1.8

26.9

387

2148

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

1.7

26.8

496

2962

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

2.8

26.8

132

472

F44.9

ICD-10 Finland

Dissociative [conversion] disorder, unspecified

4.5

26.7

146

S18

ICPC

Laceration/cut

1.3

26.5

4204

36471

X58

ICD-10 Finland

Exposure to other specified factors

1.4

26.5

1321

9776

TPX22

NOMESCO Finland

Intravenous arterial thrombolysis

3.4

26.5

282

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

1.8

26.5

373

2057

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.7

26.3

504

3037

G91.2

ICD-10 Finland

Normal-pressure hydrocephalus

2.8

26.3

127

449

SPAT1296

SPAT

Other function in accordance with occupational therapy nomenclature

3.0

26.3

119

406

J01EA01

ATC

trimethoprim; systemic

1.3

26.2

2075

16498

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

2.0

26.1

300

1547

SPAT1304

SPAT

Counselling and guidance related to ageing

1.6

26.0

580

3634

CS424

NOMESCO Finland

Visual field testing with Goldmann perimetry

3.2

26.0

100

310

J01DB01

ATC

cefalexin; oral

1.3

26.0

7915

73917

I60.7

ICD-10 Finland

Subarachnoid haemorrhage from intracranial artery, unspecified

5.3

26.0

C71.40

ICD-10 Finland

Malignant tumor of the occipital lobe without histology

60.1

25.9

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

2.5

25.8

169

696

PA2KT

NOMESCO Finland

Endovascular closure of brain aneurysm

7.0

25.8

W10

ICD-10 Finland

Fall on and from stairs and steps

1.7

25.8

458

2704

RS122, ,

NOMESCO Finland

5.5

25.8

3018D

ICD-9 Finland

Personality disorders, Other personality disorders[EPÄVAKAA PERSOONALLISUUS]

4.5

25.6

139

F72.0

ICD-10 Finland

Severe mental retardation, with the statement of no, or minimal, impairment of behaviour

33.1

25.5

R60.0

ICD-10 Finland

Localized oedema

1.4

25.4

1082

7785

PA2BG

NOMESCO Finland

MRI examination of vessels in the head with high intensity magnet

3.8

25.4

209

D33.9

ICD-10 Finland

Benign neoplasm: Central nervous system, unspecified

9.4

25.3

XX9BW

NOMESCO Finland

Submitting image material and/or investigation material to authority or other institution

2.6

25.2

147

573

9440/3-C71.3

ICD-O-3

Glioblastoma, NOS, of parietal lobe

50.1

25.2

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.5

25.1

832

5700

XXA00

NOMESCO Finland

Clinical examination requiring general anaesthesia

3.8

25.1

197

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.5

25.0

882

6123

SPAT1263

SPAT

Sampling

1.3

25.0

3672

31520

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.5

25.0

952

6709

SPAT1260

SPAT

Consultation of another employee

1.4

24.9

1461

11097

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

2.0

24.8

283

1456

N05BA02

ATC

chlordiazepoxide; systemic

2.2

24.7

199

897

M01AH05

ATC

etoricoxib; oral

0.8

24.6

4341

48947

E86

ICD-10 Finland

Volume depletion

2.1

24.6

227

1081

SPAT1172

SPAT

Guidance concerning hydration

2.2

24.4

207

953

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

1.9

24.4

313

1675

R33

ICD-10 Finland

Retention of urine

1.5

24.4

694

4605

N06AX22

ATC

agomelatine; oral

2.2

24.3

205

942

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

1.8

24.3

404

2341

AAK80

NOMESCO Finland

Partial excision of skull cap

20.1

24.2

C07AB07

ATC

bisoprolol; oral

1.2

24.2

4168

36369

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.6

24.2

525

3267

ZXE17

NOMESCO Finland

Procedure duration 150 to 179 minutes

2.9

24.1

110

377

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.1

24.1

237

1157

C71.83

ICD-10 Finland

Overall malignant tumor of the brain grade IV glioma

56.1

24.0

YX9AD

NOMESCO Finland

Other CT eamination for dose design of radiotherapy

2.2

24.0

204

941

AAJ10

NOMESCO Finland

Lobectomy for epilepsy

+∞

24.0

C79.31

ICD-10 Finland

Secondary malignant tumor of the cerebellum

5.6

23.9

K59.09

ICD-10 Finland

Constipation, unspecified

1.6

23.8

602

3890

F07.2

ICD-10 Finland

Postconcussional syndrome

7.7

23.8

N05AF05

ATC

zuclopenthixol; systemic

3.3

23.7

267

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.4

23.6

1026

7406

EBA00

NOMESCO Finland

Extraction of tooth

1.3

23.6

3259

27729

S06.9

ICD-10 Finland

Intracranial injury, unspecified

3.5

23.5

225

RT150, ,

NOMESCO Finland

4.5

23.5

128

K59.0

ICD-10 Finland

Constipation

1.6

23.4

496

3068

XFP96

NOMESCO Finland

Other intraoperative electrophysiological investigation in arhythmia or disturbance of impulse propagation

2.3

23.4

177

778

A07

ICPC

Coma

4.3

23.3

141

F06.2

ICD-10 Finland

Organic delusional [schizophrenia-like] disorder

7.5

23.3

FPK00

NOMESCO Finland

Implantation of electrocardiograph with loop recorder

3.7

23.3

203

D64.9

ICD-10 Finland

Anaemia, unspecified

1.4

23.2

933

6637

G43.9

ICD-10 Finland

Migraine, unspecified

1.7

23.2

483

2976

R26.8

ICD-10 Finland

Other and unspecified abnormalities of gait and mobility

2.2

23.1

194

890

PA2LT

NOMESCO Finland

Endovascular closure of extensive brain aneurysm

5.2

23.1

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.3

23.0

1558

12083

S02.00

ICD-10 Finland

Fracture of the upper part of the head closed

4.6

23.0

118

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

1.8

23.0

341

1911

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.2

22.9

189

861

I60.2

ICD-10 Finland

Subarachnoid haemorrhage from anterior communicating artery

4.2

22.9

143

M41.4

ICD-10 Finland

Neuromuscular scoliosis

8.5

22.7

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

2.4

22.6

148

610

P15

ICPC

Chronic alcohol abuse

2.0

22.6

263

1363

85190

ICD-8 Finland

Cerebral laceration and contusion, Late effect

9.3

22.6

AAU00

NOMESCO Finland

Removal of implant or external fixation device from skull

120.2

22.6

S82.6

ICD-10 Finland

Fracture of lateral malleolus

1.6

22.5

505

3169

AA1AA

NOMESCO Finland

Head X-ray examination

3.2

22.5

281

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

1.6

22.5

534

3397

G80.0

ICD-10 Finland

Spastic quadriplegic cerebral palsy

20.7

22.5

S72.0

ICD-10 Finland

Fracture of neck of femur

1.8

22.3

337

1899

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.4

22.3

1089

8018

7840A

ICD-9 Finland

Symptoms involving head and neck, Headache

3.1

22.2

309

TAA40

NOMESCO Finland

Cathetrisation of cerebrospinal fluid through skin

5.8

22.2

SPAT1167

SPAT

Insertion of urinary catheter

1.9

22.2

273

1442

ZXA05

NOMESCO Finland

Left side

1.3

22.2

1965

15816

C10AA01

ATC

simvastatin; oral

1.2

22.1

3381

29038

I60.3

ICD-10 Finland

Subarachnoid haemorrhage from posterior communicating artery

7.9

22.1

PA2VT

NOMESCO Finland

Intravascular evacuation of brain artery embolus

3.8

22.0

174

C79.3

ICD-10 Finland

Secondary malignant neoplasm of brain and cerebral meninges

7.3

22.0

F06.7

ICD-10 Finland

Mild cognitive disorder

2.0

22.0

254

1314

RS211, ,

NOMESCO Finland

4.3

21.9

131

AA5FK

NOMESCO Finland

Functional assessment (fMRI) of brain

+∞

21.9

9450/3-C71.9

ICD-O-3

Oligodendroglioma, NOS, of brain, NOS

+∞

21.9

34531

ICD-8 Finland

Epilepsy, Patrialis (focalis) Jackson

+∞

21.9

G44.2

ICD-10 Finland

Tension-type headache

1.4

21.9

1101

8147

Z43.0

ICD-10 Finland

Attention to tracheostomy

8.5

21.9

EBA15

NOMESCO Finland

Extraction of multiple teeth

1.8

21.8

342

1950

R62.0

ICD-10 Finland

Delayed milestone

3.4

21.7

232

A46

ICD-10 Finland

Erysipelas

1.4

21.7

1243

9392

D33.05

ICD-10 Finland

Other lateral benign tumor in temporal lobe

25.0

21.7

N06AB03

ATC

fluoxetine; oral

1.4

21.6

944

6814

S01.9

ICD-10 Finland

Open wound of head, part unspecified

2.2

21.6

171

767

C71

ICD-10 Finland

Malignant neoplasm of brain

115.2

21.6

I61.4

ICD-10 Finland

Intracerebral haemorrhage in cerebellum

6.1

21.5

JDB10

NOMESCO Finland

Percutaneous gastrostomy

2.7

21.5

116

436

I68.0*E85.9

ICD-10 Finland

Cerebral amyloid angiopathy

7.9

21.2

F60.9

ICD-10 Finland

Personality disorder, unspecified

2.6

21.2

118

450

RS230, ,

NOMESCO Finland

3.8

21.2

165

AAF99

NOMESCO Finland

Other shunt operation on ventricle of brain or intracerebral cyst

7.2

21.1

I67.9

ICD-10 Finland

Cerebrovascular disease, unspecified

3.0

21.1

308

RS121, ,

NOMESCO Finland

3.4

21.1

217

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

1.8

21.1

343

1977

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

1.9

21.0

282

1533

ZXD10

NOMESCO Finland

Scheduled procedure

1.2

21.0

3158

27042

XF404

NOMESCO Finland

Ambulatory ECG

1.5

20.9

703

4827

WX725

NOMESCO Finland

Noninvasive ventilation

1.6

20.9

460

2874

C71.80

ICD-10 Finland

Overall malignant tumor of the brain without histology

28.1

20.9

34300

ICD-8 Finland

Cerebral spastic infantile paralysis, Hemiplegia spastica

60.1

20.8

C71.39

ICD-10 Finland

Malignant tumor of parietal lobe other or unspecified histology

60.1

20.8

N05BA12

ATC

alprazolam; oral

1.5

20.8

758

5289

G93.4

ICD-10 Finland

Encephalopathy, unspecified

5.6

20.8

S72.1

ICD-10 Finland

Pertrochanteric fracture

2.1

20.8

192

916

WF004

NOMESCO Finland

Palliative radiotherapy

2.1

20.7

185

871

96610

ICD-8 Finland

Adverse effect of anticonvulsants, Hydantoin derivatives

76.9

20.7

F06.0

ICD-10 Finland

Organic hallucinosis

5.7

20.6

H55

ICD-10 Finland

Nystagmus and other irregular eye movements

4.2

20.6

129

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.5

20.6

736

5118

WF029

NOMESCO Finland

Radiotherapy of local residive tumor

3.6

20.5

192

R56

ICD-10 Finland

Convulsions, not elsewhere classified

30.1

20.5

D33.08

ICD-10 Finland

Another benign tumor of the cerebral ventricle

30.1

20.5

E87.8

ICD-10 Finland

Other disorders of electrolyte and fluid balance, not elsewhere classified

5.8

20.5

N05AN01

ATC

lithium; oral

2.1

20.5

195

941

F61.0

ICD-10 Finland

Mixed personality disorders

2.4

20.5

145

620

N06DA03

ATC

rivastigmine; oral, transdermal

1.7

20.5

359

2113

F00.00*G30.0

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset without additional symptoms

3.4

20.3

208

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.3

20.3

2078

17012

SPAT1210

SPAT

Application of cast or individual aid

1.8

20.3

320

1828

G30.0

ICD-10 Finland

Alzheimer disease with early onset

3.0

20.2

289

J01CA08

ATC

pivmecillinam; oral

1.2

20.2

3095

26527

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

2.8

20.2

101

365

XX3XW, ,

NOMESCO Finland

3.5

20.0

191

F41.09

ICD-10 Finland

UNS Panic Syndrome

1.9

19.9

246

1302

SPAT1153

SPAT

Removal of sutures

1.3

19.9

2542

21352

W06

ICD-10 Finland

Fall involving bed

3.0

19.8

282

J01DA01

ATC

[U] cefalexin

1.2

19.8

5398

48974

P03

ICPC

Feeling depressed

1.4

19.8

836

5995

C71.82

ICD-10 Finland

Overall malignant tumor of the brain grade III glioma

+∞

19.8

N03AF03

ATC

rufinamide; oral

+∞

19.8

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

1.9

19.8

245

1298

SPAT1249

SPAT

Treatment-related counselling outside office

1.2

19.8

3324

28754

NB6AA

NOMESCO Finland

Humerus X-ray examination

2.1

19.7

193

941

ZXA00

NOMESCO Finland

Right side

1.3

19.7

2089

17162

F43.21

ICD-10 Finland

Adaptation disorder with prolonged depression

2.9

19.7

310

S42.0

ICD-10 Finland

Fracture of clavicle

1.9

19.6

244

1294

WZC30

NOMESCO Finland

Teaching

1.3

19.6

1355

10523

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

1.9

19.6

229

1190

R13

ICD-10 Finland

Dysphagia

1.5

19.5

569

3793

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.4

19.5

775

5496

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.5

19.5

686

4753

N30.9

ICD-10 Finland

Cystitis, unspecified

1.5

19.5

530

3481

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

1.7

19.4

363

2174

U07.2

ICD-10 Finland

COVID-19, virus not identified

0.7

19.2

979

12995

N27

ICPC

Fear of neurological disease other

2.2

19.2

156

707

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.2

19.2

3639

31839

307

Kela drug reimbursment

Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease

1.8

19.2

292

1650

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

2.7

19.2

104

392

N06AX21

ATC

duloxetine; oral

1.4

19.2

921

6755

ZX120

NOMESCO Finland

Intravenous

1.4

19.1

749

5299

SPAT1310

SPAT

Counselling related to known health issue

1.2

19.0

2621

22180

SPAT1251

SPAT

Organisation of medication

1.8

19.0

283

1589

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

1.6

18.9

441

2794

XF600

NOMESCO Finland

Bloodpressure measurement

1.5

18.9

547

3640

K92.0

ICD-10 Finland

Haematemesis

2.0

18.9

207

1052

L89

ICD-10 Finland

Decubitus ulcer and pressure area

2.1

18.9

168

791

S01.1

ICD-10 Finland

Open wound of eyelid and periocular area

1.9

18.8

232

1228

78259

ICD-8 Finland

Symptoms referable to cardiovascular and lymphatic system, Syncope (lipothymia) alia sive NUD

5.8

18.8

C09AA05

ATC

ramipril; oral

1.3

18.8

1996

16397

AA11X, ,

NOMESCO Finland

+∞

18.7

3456B

ICD-9 Finland

Epilepsy, Infantile spasms[EPILEPSIA MYOCLONICA CUM ASTASIA]

+∞

18.7

9451/3-C71.1

ICD-O-3

Oligodendroglioma, anaplastic, NOS, of frontal lobe

+∞

18.7

9531/0-C70.0

ICD-O-3

Meningothelial meningioma of cerebral meninges

15.8

18.7

D42.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Cerebral meninges

17.1

18.6

R1210

NOMESCO Finland

Medical assessment of need and possibilities to rehabilitation

2.7

18.6

370

AAL10

NOMESCO Finland

Intracranial endovascular thrombolysis

3.5

18.6

181

N05BE01

ATC

buspirone; oral

1.9

18.6

229

1212

N06AG02

ATC

moclobemide; oral

1.7

18.6

321

1883

9400/3-C71.2

ICD-O-3

Astrocytoma, NOS, of temporal lobe

100.2

18.5

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

1.6

18.5

417

2620

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

2.0

18.5

197

991

9382/3-C71.1

ICD-O-3

Oligoastrocytoma, NOS, of frontal lobe

190.2

18.5

AAA40

NOMESCO Finland

Insertion of intracerebral electrodes

190.2

18.5

ZY000

NOMESCO Finland

Hospital inpatient

2.5

18.4

115

465

Z08

ICPC

Social welfare problem

2.4

18.4

121

501

S70.0

ICD-10 Finland

Contusion of hip

1.7

18.3

328

1942

2968A

ICD-9 Finland

Affective psychoses, Manic-depressive psychosis, other and unspecified

2.8

18.3

317

Z3229

NOMESCO Finland

Other healthcare associate professional

1.5

18.3

682

4778

4340A

ICD-9 Finland

Occlusion of cerebral arteries, Cerebral thrombosis

3.0

18.3

269

5AB01, ,

NOMESCO Finland

6.6

18.3

F10.2

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Dependence syndrome

2.7

18.2

351

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.4

18.2

1031

7767

YX8AD

NOMESCO Finland

Stereotactic CT examination for dose design of radiotherapy

7.1

18.2

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

2.6

18.2

100

380

9537/0-C70.0

ICD-O-3

Transitional meningioma of cerebral meninges

21.7

18.1

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.5

18.1

597

4084

G04BD04

ATC

oxybutynin; oral, transdermal

1.6

18.1

391

2434

WZA90

NOMESCO Finland

Other medical or dental certificate

1.3

18.0

1954

16076

Z72.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

854

103.20

307.65

3.5

2.1

29.99

26.49

umol/l

1.53

653

(3027801) Oxygen [Partial pressure] in Arterial blood

2410

10630

2.65

307.65

8.1

7.9

13.90

12.38

kpa

25.66

2320

10209

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

1496

311.49

307.65

2.7

2.2

54.92

35.04

umol/l

3.90

1335

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

974

2233

4.71

307.65

1.5

1.6

544.02

523.20

mg/l

0.46

937

2135

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

6281

40494

2.38

307.65

8.5

7.1

1.20

1.21

mmol/l

38.93

6011

37547

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

482

465

10.81

307.65

1.8

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

2410

10635

2.64

307.65

8.1

7.9

5.05

5.08

kpa

1.10

2322

10215

(3018677) aPTT in Platelet poor plasma by Coagulation assay

3153

14093

2.77

307.65

2.4

28.79

29.82

14.64

3065

13700

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

894

1977

4.85

307.65

1.4

1.5

3.86

3.72

mmol/l

2.73

849

1866

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

5802

27254

3.54

307.65

3.7

2.2

218.44

213.16

u/l

0.12

5646

25759

(3009466) Valproate [Moles/volume] in Serum or Plasma

1838

814

27.18

307.65

4.1

6.2

368.68

357.75

umol/l

1.18

1639

701

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

840

1955

4.58

307.65

1.6

26.89

24.95

e6/l

0.09

647

1411

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

1241

3166

4.31

307.65

2.4

2.3

389.05

577.66

ug/l

1.31

1192

3003

(3019977) pH of Arterial blood

2421

10612

2.67

307.65

8.1

8.0

7.42

0.17

1531

5688

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

288

92.47

307.65

3.5

3.1

42.10

39.52

umol/l

0.21

263

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

577

816

7.42

307.65

1.7

1.3

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

845

1980

4.55

307.65

1.7

4072.00

3041.53

e6/l

0.13

689

1527

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

6690

45233

2.33

307.65

9.3

7.6

1.20

1.21

mmol/l

35.18

5985

39242

(3003396) Base excess in Arterial blood by calculation

2391

10542

2.64

307.65

8.1

7.9

1.01

0.86

mmol/l

1.13

1933

8618

(3013826) Glucose [Moles/volume] in Serum or Plasma

7198

53187

2.14

268.48

7.9

5.2

6.60

6.69

mmol/l

3.32

6980

50271

(3023183) Ammonium ion [Moles/volume] in Plasma

764

1962

4.12

263.95

2.8

31.49

34.29

umol/l

2.24

692

1775

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

418

654

6.61

254.86

1.4

1.2

2.21

2.05

mmol/l

1.33

388

607

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

138

69.87

253.98

1.1

1.0

—

(3032080) INR in Blood by Coagulation assay

5870

41325

1.96

236.61

16.7

15.5

1.24

1.27

inr

3.84

5069

34553

(3016502) Oxygen saturation in Arterial blood

1998

9521

2.36

230.23

8.9

8.2

96.11

95.57

3.42

1934

9180

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1887

8829

2.39

226.36

9.1

8.7

122.98

121.35

g/l

2.93

1850

8622

(3023368) Bacteria identified in Blood by Culture

4057

25484

1.97

226.16

4.9

4.4

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

330

455

7.45

226.01

1.2

1.1

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

305

416

7.52

210.83

1.2

1.1

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

296

412

7.36

200.93

1.7

1.3

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

2719

15422

2.03

197.88

2.2

1.9

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

2711

15386

2.03

196.80

4.0

3.8

0.81

0.82

mmol/l

2.04

2548

14524

(3020191) Ethanol [Moles/volume] in Serum or Plasma

383

735

5.37

188.63

2.1

1.4

0.68

1.35

promille

13.43

321

581

(3018418) pH of Serum or Plasma

4082

26897

1.85

187.02

4.5

4.3

7.40

1.09

3088

19167

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

4826

33521

1.82

185.59

5.2

3.8

43.18

83.78

ng/l

1.36

3769

23070

(3003181) Sodium [Moles/volume] in Urine

582

1611

3.76

179.75

1.5

69.15

63.66

mmol/l

2.02

483

1300

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

1457

6793

2.33

172.56

8.2

9.5

24.40

24.79

mmol/l

4.35

1446

6751

(3008152) Bicarbonate [Moles/volume] in Arterial blood

1266

5565

2.45

171.18

9.7

6.6

24.66

24.43

mmol/l

1.23

1218

5319

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

1260

5528

2.45

171.09

8.0

10.2

24.24

24.21

mmol/l

0.11

1242

5402

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

2094

11469

2.03

163.89

2.1

1.8

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

85.64

160.75

1.1

1.0

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1708

8758

2.13

159.16

2.5

2.3

371.68

375.85

nmol/l

0.36

1579

8140

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

1313

6056

2.33

158.62

8.9

10.1

1.35

1.32

0.43

1303

6021

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

1278

5876

2.34

155.34

9.1

10.4

0.69

0.64

5.64

1271

5839

(3014111) Lactate [Moles/volume] in Serum or Plasma

1667

8549

2.13

154.93

7.4

8.2

1.41

1.34

mmol/l

1.77

1635

8363

(3026008) Bacteria identified in Urine by Culture

3913

26818

1.73

147.22

3.8

3.2

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1948

10778

1.99

146.37

2.1

1.9

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

207

282

7.46

143.10

1.3

1.1

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

5400

40575

1.68

142.84

6.0

5.4

34.99

35.71

g/l

15.66

5107

38023

(3000991) Gas panel - Venous blood

1625

8703

2.03

132.65

8.3

9.5

—

(3023410) Appearance of Cerebral spinal fluid

373

936

4.09

131.84

1.7

2.1

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1805

10079

1.95

130.56

4.4

4.6

5.90

5.81

kpa

3.83

1760

9827

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

6006

47094

1.65

128.72

8.7

6.7

9.97

12.00

umol/l

30.46

5723

44877

(3002032) Base excess in Venous blood by calculation

1750

9849

1.93

122.96

4.4

4.6

1.89

1.69

mmol/l

1.55

1550

8546

(3024354) Oxygen [Partial pressure] in Venous blood

1564

8482

1.99

122.43

4.1

4.65

4.61

kpa

0.30

1523

8256

(3033658) Prothrombin time (PT) actual/Normal

3389

23293

1.67

120.06

5.0

4.5

88.99

88.49

0.56

3311

22803

(3020891) Body temperature

939

4226

2.34

118.44

5.7

4.6

36.91

°c

0.11

931

4180

(3018405) Lactate [Moles/volume] in Arterial blood

722

2885

2.61

117.82

4.9

3.9

1.50

1.39

mmol/l

1.25

713

2832

(3012544) pH of Venous blood

1785

10242

1.89

117.79

4.5

4.6

7.37

7.38

0.25

1098

5996

(3043409) Potassium [Moles/volume] in Arterial blood

633

2375

2.77

116.96

5.2

4.2

3.87

3.90

mmol/l

0.54

627

2352

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

207

381

5.52

106.56

1.2

1.1

—

0.11

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

165

243

6.88

106.27

1.2

1.1

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

979

4736

2.18

103.19

1.6

1.5

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

2033

12616

1.76

102.16

5.8

6.7

1.03

1.06

mmol/l

5.55

1897

11789

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

161

241

6.77

102.13

1.2

1.0

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

159

235

6.85

102.07

1.2

1.0

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

312

861

3.70

96.31

1.1

1.0

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

4091

30626

1.55

95.79

4.5

3.5

2.34

2.35

mmol/l

12.47

3746

27892

(3019309) Folate [Moles/volume] in Red Blood Cells

2314

15133

1.68

95.14

1.8

1188.29

1155.77

nmol/l

0.99

1839

11489

(3036489) Thrombin time

773

3556

2.27

91.85

2.5

2.7

21.01

21.15

0.23

708

3159

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

147

224

6.64

91.70

1.1

—

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

200

412

4.93

90.66

1.6

1.2

47.46

71.27

3.11

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

1034

5354

2.03

90.54

10.8

10.2

16.27

16.02

2.16

994

5165

(3031040) Bacteria [#/volume] in Urine by Automated count

6949

58718

1.55

90.39

6.1

4.7

3270.06

1843.59

e6/l

0.77

128

818

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

103

105

9.89

89.77

1.2

1.1

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

11.02

87.45

1.2

1.0

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

4318

33202

1.51

86.54

4.0

3.6

—

2.24

—

(3008295) Osmolality of Serum or Plasma

327

1003

3.33

85.79

1.4

1.5

277.27

280.48

mosm/kgh2o

1.38

239

762

(3020779) Urea [Moles/volume] in Serum or Plasma

1488

8865

1.79

84.46

6.7

8.1

7.99

9.87

mmol/l

22.88

1419

8500

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

957

4957

2.02

83.43

3.7

3.4

1.33

1.24

1.45

951

4930

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

181

368

4.98

83.33

1.2

1.1

523.20

300.15

ng/l

0.23

(3013650) Neutrophils [#/volume] in Blood by Automated count

6255

52250

1.49

81.11

12.6

9.8

4.08

4.14

e9/l

1.10

5490

45154

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1612

9937

1.73

80.97

9.9

7.0

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

899

4605

2.04

80.73

4.6

4.3

50.36

47.37

3.29

887

4533

(3026782) Osmolality of Urine

2580

17945

1.58

80.52

3.2

3.0

534.49

538.10

mosm/kgh2o

0.35

2298

15765

(3004119) Hemoglobin [Mass/volume] in Venous blood

1070

5849

1.92

79.64

3.9

3.8

129.52

129.51

g/l

0.00

1048

5684

(3006315) Basophils [#/volume] in Blood

5724

47149

1.47

78.38

7.6

6.6

0.04

e9/l

13.95

4966

40397

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

132

212

6.29

78.27

1.1

1.0

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

1028

5580

1.93

78.07

1.8

1.7

—

(3001604) Monocytes [#/volume] in Blood

5707

47017

1.47

77.83

7.6

6.6

0.60

0.59

e9/l

0.32

4957

40269

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

1070

5894

1.91

77.72

4.7

4.4

1.66

1.68

mmol/l

0.05

788

4327

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

261

739

3.59

77.53

1.2

1.1

40.98

41.04

mg/l

0.01

226

619

(3019198) Lymphocytes [#/volume] in Blood

5815

48115

1.47

77.32

7.8

6.7

1.83

1.92

e9/l

2.30

5133

42235

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

255

713

3.64

77.18

1.1

268.46

259.38

mg/l

0.28

233

634

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

9.64

76.18

1.2

1.1

—

(3013115) Eosinophils [#/volume] in Blood

5849

48533

1.47

76.07

8.0

6.9

0.17

0.20

e9/l

17.12

5134

42291

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

1277

7485

1.80

75.99

2.7

2.3

5.72

7.53

ug/l

4.26

1103

6544

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

1188

6825

1.83

75.50

4.7

4.5

5.21

5.12

kpa

3.07

1127

6535

(3009343) pH of Capillary blood

1158

6651

1.83

73.54

4.8

4.5

7.41

7.42

3.75

993

5483

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

3070

22578

1.51

72.92

2.6

2.5

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

811

4157

2.03

72.43

3.9

3.7

25.26

25.15

mmol/l

0.39

784

4013

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

9.51

72.05

1.2

1.1

—

(1761868) Lipid panel - Serum or Plasma

2499

33938

0.65

71.43

3.1

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

7689

67828

1.50

69.68

10.6

8.3

82.27

80.33

u/l

2.37

7363

64516

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

794

4102

2.01

69.28

8.0

4.8

1.70

1.62

1.29

749

3879

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

233

661

3.58

69.02

1.1

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

744

3775

2.04

68.22

8.4

5.0

0.91

0.88

1.24

700

3564

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

3711

28735

1.45

66.41

3.3

2.7

57.76

63.26

u/l

1.01

3467

26727

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

1077

6250

1.81

65.72

4.3

5.0

24.25

24.09

mmol/l

1.01

1063

6185

(3016038) Potassium [Moles/volume] in Urine

218

620

3.57

64.35

1.3

1.4

33.64

35.68

mmol/l

0.64

189

549

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

108

173

6.29

64.24

1.1

1.4

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

2433

17461

1.51

63.32

3.2

3.0

2.44

2.45

mmol/l

6.40

2184

15602

(3002582) Erythrocytes [#/volume] in Urine

3839

30317

1.42

59.94

4.0

3.5

56.18

84.94

e6/l

1.73

3109

23205

(4035726) Immunohistochemistry procedure

1230

7605

1.70

59.73

1.4

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

281

976

2.93

59.64

1.5

1.7

—

(4027681) Cerebrospinal fluid IgG ratio and IgG index

197

551

3.62

59.64

1.3

1.2

0.55

0.64

ratio

2.06

119

323

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

5076

42185

1.39

58.32

3.2

2.9

—

estimate

—

(3021960) Folate [Moles/volume] in Serum or Plasma

3309

25617

1.43

57.03

1.9

1.7

18.83

19.91

nmol/l

4.15

2919

21948

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3829

30452

1.41

56.44

4.3

3.4

31.87

34.00

u/l

0.91

3622

28755

(3019069) Monocytes/Leukocytes in Blood

5170

43430

1.38

53.88

7.9

7.0

9.16

8.86

10.03

4900

40785

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

2387

17542

1.47

53.81

4.7

4.0

223.08

481.72

ng/l

3.62

1847

13608

(3000850) Epithelial cells [#/volume] in Urine

2779

21017

1.44

53.80

3.1

2.8

6.15

5.33

e6/l

2.18

2607

19112

(3039000) Anion gap in Blood by calculation

417

1849

2.31

53.63

11.6

6.4

11.08

11.35

mmol/l

0.77

377

1651

(3018572) Chloride [Moles/volume] in Blood

417

1850

2.30

53.56

11.6

6.4

104.46

105.06

mmol/l

1.28

377

1653

(3006504) Eosinophils/Leukocytes in Blood

5154

43338

1.37

53.05

7.8

6.9

2.59

2.87

15.25

4889

40684

(3047181) Lactate [Moles/volume] in Blood

547

2716

2.07

52.95

10.2

5.4

1.48

1.32

mmol/l

1.90

483

2390

(3022096) Basophils/Leukocytes in Blood

5148

43306

1.37

52.70

7.9

7.0

0.64

0.67

5.80

4884

40628

(3028271) Lactate [Moles/volume] in Capillary blood

344

1422

2.47

51.79

2.2

1.9

2.18

1.68

mmol/l

7.72

337

1389

(4198724) Urine methamphetamine measurement

166

460

3.65

51.00

1.8

2.9

—

(3030467) Casts [#/volume] in Urine by Automated count

3336

26267

1.40

50.70

3.8

3.4

0.40

0.42

e6/l

0.19

2623

19335

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1075

6715

1.67

49.71

1.9

1.7

—

(3028707) Methadone [Presence] in Urine by Screen method

397

1793

2.26

48.86

2.8

3.0

—

(3002030) Lymphocytes/Leukocytes in Blood

5242

44532

1.35

48.81

7.8

6.9

26.86

27.92

9.10

5021

42242

(3018010) Neutrophils/Leukocytes in Blood

5147

43670

1.35

47.97

7.7

6.7

57.66

57.14

2.26

4956

41763

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

12.41

47.74

1.0

1.1

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

606

3239

1.92

47.50

2.1

1.8

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

546

2830

1.98

46.83

1.3

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

117

270

4.37

46.27

1.4

1.2

25.38

26.74

0.06

(3012501) Base excess in Blood by calculation

402

1867

2.20

46.22

4.4

2.35

2.46

mmol/l

0.37

285

1235

(3019150) Specific gravity of Urine by Refractometry

2768

21379

1.40

46.20

5.1

4.0

1.02

1.16

kg/l

0.81

1886

14228

(3013290) Carbon dioxide [Partial pressure] in Blood

402

1868

2.20

46.15

4.4

5.06

4.98

kpa

1.58

392

1825

(3027315) Oxygen [Partial pressure] in Blood

403

1878

2.19

45.94

4.4

8.65

8.71

kpa

0.23

393

1834

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1604

11194

1.51

45.86

2.3

1.8

1.70

1.45

20.83

1438

9828

(3029937) Albumin [Presence] in Urine by Test strip

3298

26279

1.37

45.37

5.1

4.1

0.00

estimate

3.64

1050

9116

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

239

883

2.75

45.26

1.6

1.8

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

615

3358

1.88

45.13

3.2

24.60

24.64

mmol/l

0.10

607

3299

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

176

553

3.22

44.48

1.0

359.11

311.65

ng/l

0.31

136

387

(3018095) Leukocytes [#/volume] in Urine

4167

34509

1.34

44.35

4.8

4.1

96.44

92.96

e6/l

0.07

3168

24397

(1616796) Gas panel - Central venous blood

430

2095

2.10

43.72

3.9

4.0

—

(3028626) Oxygen [Partial pressure] in Capillary blood

571

3083

1.90

43.35

5.3

4.9

8.68

8.60

kpa

0.42

557

3012

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

3123

24809

1.37

43.33

2.4

2.80

2.79

mg/l

0.09

2669

21544

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

174

557

3.16

42.65

1.0

37.83

41.31

ng/l

0.62

131

387

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

658

3737

1.81

42.52

2.4

1.9

2.56

2.21

ug/l

0.27

559

3314

(36304419) Bacteria [Presence] in Urine

3142

25053

1.36

42.35

3.8

3.4

1.41

131.94

estimate

0.62

118

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

7.11

42.23

1.1

—

(3015736) pH of Urine

4583

38709

1.33

41.74

4.2

3.5

6.48

6.22

41.37

2481

21548

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

172

554

3.14

41.73

1.0

704.17

746.34

ng/l

0.54

129

373

(40767503) Oxygen content in Capillary blood by calculation

401

1937

2.11

41.70

2.8

2.7

16.84

16.47

1.63

391

1901

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

549

2965

1.90

41.63

3.1

3.3

3.41

3.53

g/l

1.09

527

2838

(3010421) pH of Blood

533

2872

1.90

40.69

4.2

4.0

7.41

0.67

523

2833

(3037467) Urinalysis macro (dipstick) panel - Urine

6842

61317

1.33

40.34

5.6

4.6

2.29

2.45

—

(3019225) pH of Specimen

1213

8213

1.54

39.51

4.6

4.3

7.36

7.35

1.02

1033

5897

(3020951) Lymphocytes/Leukocytes in Cerebral spinal fluid

100

6.43

39.07

1.5

1.1

48.83

58.61

0.63

(3035350) Ketones [Presence] in Urine by Test strip

5532

48263

1.31

38.69

4.8

3.9

5.73

3.91

estimate

0.29

1171

10159

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

555

3096

1.84

37.97

3.5

3.9

0.36

0.34

iu/ml

0.52

354

1695

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

592

9835

0.58

36.29

1.8

1.9

3.53

ratio

0.01

435

7492

(3009261) Glucose [Presence] in Urine by Test strip

5533

48547

1.30

35.78

4.8

3.9

1.82

0.16

estimate

0.71

1105

9599

(3021601) Nitrite [Presence] in Urine by Test strip

5447

47727

1.29

35.45

4.8

3.9

0.00

estimate

2.57

1130

9964

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

150

498

3.04

34.62

1.1

1.10

1.13

u/l

0.19

203

(3011397) Hemoglobin [Presence] in Urine by Test strip

2768

22179

1.34

34.61

4.5

3.8

0.23

0.41

0.29

229

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1510

10957

1.44

34.53

4.5

4.6

250.45

242.45

u/l

0.58

1423

10397

(3045716) Anion gap in Serum or Plasma by calculation

230

955

2.44

34.37

3.1

3.2

11.20

10.60

mmol/l

0.98

230

940

(3007853) Bacteria identified in Skin by Aerobe culture

1525

11097

1.44

34.33

1.9

1.8

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

651

3925

1.70

34.00

5.6

4.9

24.74

24.67

mmol/l

0.27

606

3647

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

138

441

3.16

34.00

2.1

2.2

134.63

150.08

umol/l

0.24

235

(3022806) Fractional oxyhemoglobin in Capillary blood

245

1056

2.35

33.69

2.2

1.9

89.43

89.79

0.46

238

1043

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

6672

60302

1.29

32.84

4.7

3.4

65.82

46.72

u/l

27.13

6389

56831

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

2511

19962

1.34

32.80

2.1

1.9

1.19

1.25

mg/l

0.38

1970

15416

(3019550) Sodium [Moles/volume] in Serum or Plasma

9239

87657

1.46

32.65

31.1

19.0

138.42

139.67

mmol/l

232.46

9117

85912

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

596

3551

1.72

32.49

2.2

2.0

—

(3021901) Oxygen saturation in Capillary blood

386

2017

1.95

32.29

2.9

3.2

90.44

89.95

0.65

376

1968

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

4584

39593

1.28

32.07

2.3

2.1

94.36

95.54

pmol/l

0.96

2608

21414

(3022313) Gas panel - Capillary blood

754

4798

1.62

31.88

5.2

4.7

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

7895

83993

0.75

31.78

5.0

4.9

1.46

1.43

mmol/l

4.42

7369

78447

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

5.78

31.35

1.1

—

(40758558) Short blood count panel - Blood

3307

27487

1.30

30.97

8.3

6.6

—

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

418

7311

0.55

30.65

1.6

3.49

3.47

mmol/l

0.12

271

4963

(3027945) Reticulocytes/Erythrocytes in Blood

1499

11131

1.40

29.74

3.0

2.8

1.82

1.75

1.83

1327

9948

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

8105

85686

0.76

28.85

5.7

5.6

2.62

2.69

mmol/l

10.93

7586

80170

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

485

2821

1.75

28.79

3.5

3.2

186.97

190.37

0.37

461

2699

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

2094

16476

1.34

28.76

3.4

3.1

1.17

1.27

e6/l

0.19

1172

8846

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

269

1287

2.12

28.74

5.8

6.7

10.85

11.68

mg/l

2.13

238

1197

(21494755) Public health laboratory ask at order entry panel

521

8444

0.60

28.60

1.3

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

3175

26533

1.28

27.76

3.3

3.4

1388.01

1511.22

ng/l

0.81

2775

22922

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

125

428

2.94

27.42

2.6

2.4

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

9218

87871

1.41

27.39

30.5

19.2

3.97

mmol/l

0.29

9083

85966

(3042936) Bacteria identified in Isolate by Culture

1719

13214

1.36

27.38

2.3

2.0

—

(3023520) Reticulocytes [#/volume] in Blood

1185

8559

1.43

27.34

2.8

2.7

69.89

68.87

e9/l

0.41

860

6231

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

7989

84490

0.77

27.16

5.0

4.54

4.58

mmol/l

3.51

7496

79378

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1234

9025

1.42

26.50

2.5

0.21

g/l

0.58

1144

8430

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

116

4.93

26.40

1.1

1.0

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

7.11

26.22

1.1

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

2307

18612

1.31

26.17

1.7

27193441.01

28701759.79

pmol/l

0.05

1938

15616

(3028679) Herpes simplex virus Ab [Presence] in Serum

137

506

2.73

26.13

1.2

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1921

15153

1.33

25.54

3.6

3.3

3.54

2.35

e6/l

3.90

993

7496

(3052851) Hemolysis interference index of Serum or Plasma

438

2576

1.73

25.00

3.6

3.3

2.90

2.15

index

0.77

257

1351

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

119

4.72

24.67

1.1

1.0

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

501

3079

1.66

24.27

2.9

3.3

95.69

92.78

1.88

482

2979

(3024869) Neuronal Ab [Presence] in Serum

145

4.29

24.26

1.1

—

(3014271) Vancomycin [Susceptibility]

114

398

2.88

24.20

2.9

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

621

4038

1.57

23.85

2.0

1.7

0.31

mg/l

0.03

326

1909

(3018562) Neutrophils/Leukocytes in Cerebral spinal fluid

8.02

23.84

1.7

1.2

29.63

37.33

0.36

(3005719) IgG [Mass/volume] in Serum or Plasma

1019

7357

1.43

23.39

2.7

2.9

10.15

10.53

g/l

1.65

940

6806

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

19.49

23.37

1.1

1.0

—

(3024928) Oxygen saturation in Venous blood

416

2463

1.72

23.19

3.8

4.0

62.77

62.21

0.19

396

2391

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

828

5787

1.47

22.59

1.3

45.40

52.77

au/ml

0.40

369

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

182

823

2.23

22.50

2.6

3.0

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

337

1900

1.80

22.29

1.4

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

337

1900

1.80

22.29

1.4

1.3

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

4109

36025

1.23

22.21

4.9

3.8

0.76

0.25

estimate

0.44

950

8257

(3040151) Glucose [Moles/volume] in Capillary blood

225

1113

2.04

22.08

8.3

6.3

7.31

mmol/l

0.00

196

936

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

881

6264

1.44

21.94

2.4

25.04

20.70

au/ml

0.64

683

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

5.89

20.82

1.3

1.5

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

523

3377

1.58

20.70

2.6

2.2

—

(3020630) Protein [Mass/volume] in Serum or Plasma

1048

7769

1.39

20.53

2.3

2.6

65.81

66.25

g/l

0.98

950

7122

(3042847) Granulocytes/Leukocytes in Cerebral spinal fluid

5.71

20.17

1.2

1.1

11.83

20.06

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

409

2511

1.65

19.92

1.6

1.7

—

(44790047) Parainfluenza type 1 nucleic acid detection

238

1249

1.93

19.78

1.4

1.6

—

(44806118) Parainfluenza type 4 nucleic acid detection

238

1249

1.93

19.78

1.4

1.6

—

(44790048) Parainfluenza type 2 nucleic acid detection

238

1249

1.93

19.78

1.4

1.6

—

(44790049) Parainfluenza type 3 nucleic acid detection

238

1249

1.93

19.78

1.4

1.6

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

342

2.82

19.72

1.1

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

378

2297

1.67

19.17

2.3

132.15

129.80

g/l

1.21

325

1792

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

3161

36239

0.82

19.15

1.9

1.37

1.36

mmol/l

0.12

2740

30753

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

394

2430

1.64

18.86

1.6

—

(3016879) Cocaine [Presence] in Urine

592

4013

1.50

18.77

2.5

2.2

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

1013

7579

1.37

18.69

2.8

2.6

0.47

0.44

e6/l

0.17

980

7273

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

331

2.79

18.58

3.0

2.5

141.07

143.19

nmol/l

0.08

289

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

9076

87173

1.31

18.49

25.9

16.2

24.73

24.78

mg/l

0.05

8130

71862

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

141

3.84

18.31

1.1

2.5

—

(3021589) Normoblasts [#/volume] in Blood

4541

40732

1.20

18.17

14.0

11.8

0.00

e9/l

0.55

3681

33029

(3011288) Drugs identified in Urine by Screen method Nominal

459

2965

1.57

18.15

3.4

3.1

—

(40757494) Bilirubin.total [Moles/volume] in Blood

113

460

2.47

17.84

2.3

2.6

39.99

51.01

umol/l

0.22

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

627

4358

1.47

17.54

1.9

1.7

1.49

1.51

g/l

0.28

512

3782

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

7247

68009

1.21

17.39

4.8

4.3

14.36

14.77

pmol/l

33.95

6723

62604

(3022948) Iron [Moles/volume] in Serum or Plasma

1977

16379

1.25

17.08

2.7

12.63

13.04

umol/l

1.59

1819

15290

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

7616

80012

0.82

16.89

4.3

4.2

1.29

1.28

mmol/l

0.21

7066

74046

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1854

15283

1.26

16.69

2.7

2.29

2.32

g/l

2.05

1706

14143

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

349

2155

1.64

16.67

1.4

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

417

2689

1.57

16.64

1.7

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

941

7085

1.36

16.62

4.2

4.1

1.21

1.23

mmol/l

8.84

874

6119

(3000764) Benzodiazepines [Presence] in Urine

613

4295

1.45

16.45

2.5

2.1

—

(3017569) Oxygen content in Arterial blood

116

497

2.35

16.40

1.9

2.2

15.71

16.07

0.55

116

497

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

116

3.98

16.39

1.7

1.8

—

(3027008) Opiates [Presence] in Urine

615

4320

1.45

16.28

2.4

2.0

—

(3028300) Cannabinoids [Presence] in Urine

615

4328

1.45

16.12

2.5

2.1

—

(3044242) Glucose [Moles/volume] in Arterial blood

114

498

2.30

15.45

2.2

2.0

7.69

7.98

mmol/l

0.30

114

498

(3019230) Fractional oxyhemoglobin in Venous blood

336

2102

1.62

15.25

3.7

3.9

62.23

62.65

0.13

336

2096

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1477

17977

0.79

14.86

3.0

3.2

0.75

0.78

ug/l

0.29

1027

11723

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

312

1935

1.63

14.68

1.7

1.6

—

(3008037) Lactate [Moles/volume] in Venous blood

346

2205

1.59

14.56

4.2

3.2

1.69

1.59

mmol/l

0.61

338

2143

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

245

1432

1.73

14.44

1.4

1.3

4.63

4.37

u/ml

0.10

120

673

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

137

3.51

14.38

1.1

—

(3027944) Amphetamines [Presence] in Urine

596

4260

1.42

14.36

2.2

2.0

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

333

2118

1.59

14.14

1.5

1.7

—

(3011985) Renin [Units/volume] in Plasma

229

1324

1.74

14.04

1.6

1.5

59.17

70.75

mu/l

0.43

210

1183

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1131

8951

1.29

14.01

4.3

3.5

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

460

3169

1.47

13.50

2.6

2.7

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1691

14120

1.23

13.25

2.8

22.41

22.55

0.13

1554

13138

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

144

3.27

12.66

2.2

2.0

—

(3004809) Band form neutrophils/Leukocytes in Blood

253

1550

1.65

12.56

3.1

3.7

1.46

1.60

0.22

231

1379

(4034850) Laboratory test

391

2649

1.49

12.50

12.4

10.2

—

(3011412) CD3 cells [#/volume] in Blood

175

969

1.82

12.48

2.4

2.7

1123.00

1208.41

e6/l

0.56

151

825

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

187

3190

0.58

12.44

1.1

0.62

0.64

ratio

0.16

382

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

108

507

2.14

12.38

1.1

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

734

5567

1.34

12.31

2.9

3.4

4.30

4.51

pmol/l

6.62

665

4982

(40757373) Influenza virus identified in Isolate

163

3.08

12.17

1.6

1.5

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1101

8877

1.27

11.69

2.7

2.6

40.57

43.83

u/l

0.18

931

7524

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

152

3.10

11.62

2.2

1.9

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

4451

40818

1.16

11.58

2.6

2.5

74.09

76.44

nmol/l

6.27

4020

37211

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

108

525

2.07

11.35

1.2

1.1

1624.06

1542.70

miu/ml

0.30

108

525

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

208

1246

1.68

11.31

1.2

1.4

768.18

349.08

pmol/l

0.42

180

1060

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

261

1660

1.59

11.17

1.8

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

3.98

11.16

1.1

1.0

—

(3045414) Leukocytes [Presence] in Urine

1073

8675

1.26

11.11

2.2

2.1

0.01

estimate

0.19

189

1796

(3008757) Leukocyte morphology finding [Identifier] in Blood

166

939

1.78

11.08

3.4

4.2

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

407

2848

1.45

11.07

2.2

1.7

0.23

g/l

0.53

389

2717

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

416

2930

1.44

10.93

2.2

1.7

1.19

1.18

g/l

0.05

397

2802

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

3.82

10.88

1.1

1.0

—

(3001019) Free T4 and TSH panel - Serum or Plasma

284

4249

0.66

10.79

1.6

1.7

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

234

1465

1.61

10.72

1.4

1.3

6.73

3.39

u/ml

1.24

100

524

(3017181) Myelocytes/Leukocytes in Blood

1028

8307

1.26

10.68

4.6

1.18

0.94

2.03

414

2515

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1310

10890

1.23

10.55

3.0

3.1

6.99

8.39

umol/l

2.50

1098

9533

(3028433) Virus identified in Specimen by Culture

312

2.35

10.55

1.2

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

7749

80440

0.86

10.42

6.5

6.3

38.84

39.17

mmol/mol

2.33

7261

75533

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

163

935

1.75

10.40

2.8

3.0

19.76

20.46

nmol/l

0.36

148

899

(3002179) Metamyelocytes/Leukocytes in Blood

980

7928

1.26

10.08

4.3

4.4

0.85

0.71

1.24

397

2406

(3037121) Protein [Mass/volume] in Urine

447

3239

1.40

10.03

3.9

3.7

285.86

411.44

mg/l

1.93

252

1576

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

114

592

1.93

10.01

1.4

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

296

2.34

9.91

1.4

1.5

13.30

15.45

pmol/l

1.75

246

(3017354) Segmented neutrophils/Leukocytes in Blood

167

981

1.71

9.82

2.8

3.7

60.10

57.15

1.01

144

844

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

6895

65604

1.15

9.78

4.7

4.4

12.44

11.81

mm/h

2.77

6523

61480

(3024666) Lithium [Moles/volume] in Serum or Plasma

103

521

1.99

9.77

13.3

13.7

0.61

0.62

mmol/l

0.03

482

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

135

748

1.81

9.71

1.5

1.7

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

135

748

1.81

9.71

1.5

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

135

748

1.81

9.71

1.5

1.7

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

450

2.05

9.58

4.1

2.1

153.61

148.25

0.23

433

(3014148) Varicella zoster virus Ab [Titer] in Serum

214

1349

1.60

9.58

1.2

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

204

1272

1.61

9.55

1.4

1.3

23.64

25.49

u/l

0.38

166

1052

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

111

581

1.92

9.54

1.4

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

269

1792

1.51

9.43

1.4

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

376

2674

1.42

9.42

1.3

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

113

3.19

9.41

1.9

4.3

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

17.51

9.38

1.1

1.0

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

129

713

1.82

9.37

2.4

2.8

489.34

506.36

e6/l

0.15

101

560

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

222

1420

1.57

9.35

1.4

—

(3023419) Bacteria identified in Sputum by Culture

187

1150

1.64

9.27

2.4

2.7

—

(3031659) Enterovirus Ab [Titer] in Cerebral spinal fluid

9.48

9.24

1.1

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/cells in Blood

137

779

1.77

9.07

2.3

2.4

13.83

14.48

0.29

132

761

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

130

729

1.79

9.02

2.4

2.9

210.54

220.81

e6/l

0.23

106

600

(3045424) Erythrocytes [Presence] in Urine

575

4407

1.32

9.01

2.3

2.1

0.02

0.20

estimate

0.48

157

1370

(3051611) Lipemic interference index of Serum or Plasma

152

894

1.71

8.94

3.1

3.6

13.62

13.64

index

0.01

111

532

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

104

545

1.92

8.94

2.7

2.6

42.42

39.60

0.78

293

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

354

2515

1.42

8.94

1.2

2.73

4.09

2.10

310

(40760892) CBC W Ordered Manual Differential panel - Blood

2328

20663

1.16

8.87

5.7

4.8

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

135

770

1.76

8.86

2.5

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

280

2.29

8.84

4.8

3.1

5.02

4.81

kpa

0.70

280

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

281

2.28

8.77

4.8

3.1

9.97

10.42

kpa

0.80

281

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

113

3.10

8.75

1.5

1.4

—

(4268621) Lupus anticoagulant assay

170

1037

1.65

8.73

2.5

2.3

—

(3000093) Morphology [Interpretation] in Blood Narrative

150

889

1.70

8.60

1.1

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

195

1237

1.59

8.55

1.7

1.6

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

11.55

8.55

1.3

1.0

—

(3052592) Norovirus Ag [Presence] in Stool

164

2.69

8.53

1.9

1.3

—

(1175426) CD3 cells/Lymphocytes in Blood

139

811

1.72

8.45

2.3

2.4

74.99

71.22

2.28

133

777

(3013512) EKG study

3246

29626

1.14

8.19

4.3

3.7

0.91

0.74

0.91

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

266

1823

1.47

8.17

1.4

—

(3049233) Organic acids panel - Urine

6.46

8.15

1.4

1.1

—

(3042517) Benzodiazepines panel - Urine

108

3.06

8.09

3.3

2.7

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

244

1653

1.49

7.96

3.0

3.9

603.20

1412.07

u/ml

0.75

105

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

172

1086

1.59

7.74

1.3

0.18

0.20

nmol/l

0.60

134

859

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

198

1293

1.54

7.69

1.3

0.21

0.26

nmol/l

0.36

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

310

4268

0.72

7.56

1.5

1.6

1151.90

1007.10

mu/l

0.65

256

3618

(3021440) Promyelocytes/Leukocytes in Blood

955

7951

1.22

7.53

4.7

4.6

0.16

0.12

0.75

345

2166

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

472

3618

1.32

7.44

2.5

2.4

7113.04

5671.56

u/l

0.38

146

1417

(3035285) Chloride [Moles/volume] in Venous blood

159

997

1.60

7.38

3.4

2.3

104.35

105.60

mmol/l

2.18

159

986

(3041354) Potassium [Moles/volume] in Venous blood

159

999

1.60

7.33

3.4

2.3

4.04

4.08

mmol/l

0.48

159

988

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

857

7078

1.23

7.31

4.1

4.4

82.60

90.09

ng/l

1.68

739

6175

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

107

607

1.77

7.24

2.6

3.2

93.76

97.82

0.58

102

580

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

4.29

7.20

2.4

6.2

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

454

3479

1.32

7.19

1.9

1.7

354.17

292.14

mu/l

3.17

412

3163

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

201

1338

1.51

7.18

1.2

1.1

117.81

114.77

0.64

179

1213

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

870

7217

1.22

7.11

3.1

3.2

161.39

208.85

ng/l

4.30

799

6574

(3033705) Calcium.ionized [Moles/volume] in Venous blood

155

976

1.60

7.09

3.5

2.3

1.19

1.20

mmol/l

0.75

155

965

(3028717) Thiamine [Mass/volume] in Blood

130

2.70

6.89

1.1

1.3

64.97

63.92

ug/l

0.09

130

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

864

7187

1.22

6.88

3.4

2.7

70.43

67.26

ml/min/173m2

1.26

383

3038

(3037756) Immunofixation for Serum or Plasma

268

1904

1.42

6.86

1.4

1.6

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

290

2092

1.40

6.81

5.2

6.3

305.61

1875.67

iu/ml

1.14

305

(3017509) Phencyclidine [Presence] in Urine

2.96

6.78

1.6

1.5

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

506

3979

1.28

6.63

1.7

1.6

16.79

15.77

iu/ml

0.05

110

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

194

2.32

6.53

1.1

1.2

75.29

70.60

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

292

2.06

6.47

1.1

84.95

88.67

0.28

151

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

195

2.31

6.46

1.0

1.2

65.50

78.46

—

(3000494) Fungus identified in Specimen by Culture

1270

11027

1.17

6.27

1.6

1.5

—

(3025159) Blasts/Leukocytes in Blood

952

8065

1.20

6.27

4.9

4.8

0.21

0.31

0.25

323

2089

(4195642) Thrombophilia screening test

194

1321

1.48

6.26

1.2

—

(3012787) Ethosuximide [Moles/volume] in Serum or Plasma

+∞

6.25

6.0

0.0

326.00

—

umol/l

—

(3044889) 12 lead EKG panel

6303

60347

1.11

6.24

4.4

4.0

0.50

3575.21

0.73

121

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

300

2.00

6.04

1.2

98.31

101.81

0.32

278

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

3.59

6.02

1.1

1.57

5.20

u/l

—

(40768800) Prostate Pathology biopsy report

123

1930

0.63

6.01

1.1

1.2

—

(3028026) IgM [Mass/volume] in Serum or Plasma

700

5782

1.23

5.99

1.8

2.0

1.24

1.30

g/l

0.48

634

5331

(3006245) CD3-CD19+ cells/cells in Blood

476

1.77

5.79

2.5

3.0

10.16

12.24

0.58

454

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

106

641

1.66

5.79

1.5

—

(3002079) Sodium [Moles/time] in 24 hour Urine

426

1.81

5.75

1.2

1.3

161.72

166.73

mmol/24h

0.18

426

(3023511) Choriogonadotropin [Units/volume] in Urine

235

1689

1.40

5.71

1.5

1.3

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

434

3415

1.28

5.71

1.3

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

342

1.91

5.68

4.4

2.2

168.32

169.62

0.04

327

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

155

1030

1.51

5.68

1.2

1.1

92.32

97.04

1.40

140

967

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

287

1.99

5.66

1.1

1.2

77.53

87.68

0.83

151

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

105

639

1.65

5.61

1.2

1.3

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

158

2.35

5.54

1.2

1.3

0.81

134.64

mg/l

1.69

118

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

200

1411

1.42

5.42

1.1

—

(3007449) CD3+CD8+ (T8 suppressor) cells/cells in Blood

459

1.75

5.32

2.5

2.7

28.72

28.01

0.18

442

(3017732) Neutrophils [#/volume] in Blood

1312

11563

1.15

5.31

3.8

3.2

4.17

4.56

e9/l

2.08

1127

10030

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

475

1.73

5.28

1.3

1.2

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

168

2390

0.70

5.09

1.5

52.16

60.37

ug/l

1.66

133

2005

(3050129) First trimester maternal screen panel - Serum or Plasma

203

2796

0.72

5.08

1.6

1.4

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

2216

24145

0.89

5.01

4.2

4.5

21.57

22.15

0.97

1093

11816

(3009214) Lutropin [Units/volume] in Serum or Plasma

399

3163

1.27

4.99

1.5

10.46

9.12

u/l

1.07

317

2463

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

156

2234

0.69

4.92

1.4

1.5

0.97

0.94

ratio

0.44

1355

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

156

2228

0.70

4.85

1.4

1.5

1.08

1.15

ratio

0.47

1349

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

8249

80500

1.12

4.81

6.0

5.2

1.84

1.91

mu/l

6.07

7738

74789

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

154

2199

0.70

4.79

1.4

1.5

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

157

2234

0.70

4.79

1.4

1.5

1.17

1.22

ratio

0.32

1363

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

202

2.08

4.77

2.9

2.3

1.64

1.69

mmol/l

0.03

142

(3014765) Yersinia sp identified in Stool by Organism specific culture

313

2422

1.30

4.75

1.2

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

196

2.09

4.74

1.3

1.8

21700.00

6771.11

u/ml

—

(42529406) Shigella sp [Presence] in Stool by Culture

314

2434

1.30

4.70

1.2

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

424

1.73

4.70

1.1

4.17

3.88

iu/ml

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

311

2410

1.30

4.67

1.2

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

165

1159

1.43

4.65

1.4

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

843

9734

0.85

4.59

1.6

1.7

—

6.02

—

(3023420) DNA double strand Ab [Units/volume] in Serum

464

3791

1.23

4.49

2.2

1.8

6.61

6.97

iu/ml

0.12

121

900

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

379

1.75

4.45

3.3

3.5

1.05

1.32

0.86

379

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

161

1136

1.42

4.44

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

409

1.72

4.44

1.3

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

409

1.72

4.44

1.3

1.4

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

130

1878

0.69

4.35

1.5

1.6

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

126

1830

0.68

4.34

1.5

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

177

1277

1.39

4.31

1.8

1.6

—

(3003129) Base excess in Capillary blood by calculation

155

1094

1.42

4.28

2.4

2.3

1.35

0.40

mmol/l

2.99

145

1044

(3005033) Fetal Nuchal fold Thickness US

124

1797

0.69

4.23

1.4

1.5

1.32

1.25

1.00

1305

(3013336) Amino acids [Identifier] in Serum or Plasma

3.04

4.23

4.1

3.1

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

156

1107

1.41

4.19

1.7

393.90

345.97

mu/l

0.82

128

872

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

462

1.65

4.18

1.4

1.6

2.76

6.25

nmol/l

1.40

362

(3024522) Salmonella sp identified in Specimen by Organism specific culture

160

1141

1.41

4.18

1.4

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

470

1.64

4.17

1.7

1.5

2238084.14

1556865.40

iu/ml

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

332

2637

1.27

4.15

1.4

1.5

10.50

13.06

iu/ml

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

429

3508

1.23

4.15

1.3

0.50

1.04

u/ml

1.24

291

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

2822

30132

0.91

4.14

4.8

5.5

3.28

3.02

ug/l

0.24

2517

27312

(3000060) B lymphocytes [#/volume] in Blood

374

1.71

4.09

2.3

3.0

0.86

0.48

e9/l

0.21

200

(3025468) Yersinia sp identified in Specimen by Organism specific culture

154

1096

1.41

4.08

1.4

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

347

2778

1.26

4.07

2.7

3.2

5.31

3.42

ratio

0.32

225

1601

(3003434) Protein [Mass/volume] in Pleural fluid

179

1311

1.37

4.01

1.4

1.5

33.95

31.96

g/l

1.35

170

1187

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

3.89

3.98

2.1

4.5

—

(3023199) Leukocytes [#/volume] in Pleural fluid

159

1144

1.40

3.97

1.4

1.5

2352.65

3143.83

e6/l

0.43

127

793

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

154

1102

1.40

3.97

1.4

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

432

3556

1.22

3.94

2.1

2.3

2.91

g/l

0.01

381

3238

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

103

684

1.51

3.92

1.4

1.5

12.88

12.89

u/l

0.00

103

657

(3005988) Vibrio sp identified in Specimen by Organism specific culture

154

1105

1.40

3.91

1.4

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

247

3169

0.77

3.87

1.6

1.7

6.73

4.47

mg/l

1.09

198

2326

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

598

1.54

3.87

1.8

2.7

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

321

1.75

3.85

1.5

1.4

126.07

277.55

nmol/24h

0.85

321

(3028308) Erythrocytes [#/volume] in Pleural fluid

142

1009

1.41

3.83

1.4

1.5

83008.66

55148.68

e6/l

0.49

560

(3020717) Zinc [Moles/volume] in Serum or Plasma

579

1.54

3.74

2.2

1.7

14.98

21.96

umol/l

3.26

540

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

221

1691

1.31

3.73

1.3

330.67

368.86

titre

0.07

127

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

379

3101

1.23

3.68

2.8

3.3

41.10

50.94

mg/l

0.49

331

2638

(3034860) Kappa light chains.free [Mass/volume] in Serum

379

3104

1.23

3.65

2.8

3.3

50.28

72.96

mg/l

0.66

331

2643

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

453

3785

1.21

3.58

2.0

2.3

4.13

4.21

g/l

1.24

402

3468

(4094501) Cardiovascular stress test using bicycle ergometer

180

2381

0.75

3.57

1.1

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

436

1.61

3.56

2.1

1.8

1.40

3.11

u/field

1.91

301

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

413

1.63

3.55

1.1

26.14

13.43

u/ml

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

453

3788

1.20

3.55

2.0

2.3

7.26

7.39

g/l

0.93

402

3465

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

158

1160

1.37

3.54

1.2

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

429

1.61

3.54

5.5

5.2

72.53

601.23

mg/l

0.49

313

(21494814) CD8 cells/Lymphocytes in Specimen

360

1.67

3.53

2.0

2.1

32.08

31.15

0.19

360

(3000963) Hemoglobin [Mass/volume] in Blood

9378

94846

0.88

3.49

38.6

24.6

132.37

135.51

g/l

80.40

9301

93889

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

145

1053

1.38

3.48

1.9

2.1

37.78

23.54

mg/l

1.66

379

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

451

3778

1.20

3.48

2.0

2.3

3.58

3.74

g/l

1.40

401

3461

(3001964) Herpes simplex virus Ag [Presence] in Specimen

250

1.80

3.47

1.5

1.6

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

193

1.92

3.46

1.1

1.2

349.79

284.99

pmol/l

0.42

137

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

2.42

3.46

3.1

2.4

0.67

0.55

u/field

0.22

(3026361) Erythrocytes [#/volume] in Blood

9377

94829

0.88

3.45

38.2

24.4

4.38

4.51

e12/l

116.88

9217

92603

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

266

1.77

3.41

1.4

1.3

120.63

132.88

nmol/l

0.21

197

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

9377

94822

0.89

3.41

39.0

24.9

39.47

40.96

17.91

9291

93792

(3024731) MCV [Entitic mean volume] in Red Blood Cells

9377

94820

0.89

3.40

38.1

24.4

91.20

90.83

11.99

9293

93843

(3035941) MCH [Entitic mass]

9377

94817

0.89

3.38

38.1

24.3

30.51

30.27

32.30

9292

93841

(3010813) Leukocytes [#/volume] in Blood

9380

94843

0.89

3.36

38.3

24.5

6.83

6.79

e9/l

0.81

9222

92583

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

102

701

1.46

3.34

1.2

1.3

11.46

12.69

u/l

0.57

639

(3006922) Hepatitis E virus Ab [Presence] in Serum

106

736

1.44

3.30

1.1

—

(3007461) Platelets [#/volume] in Blood

9377

94798

0.89

3.27

38.3

24.5

247.67

250.51

e9/l

3.88

9235

92840

(3033923) Metanephrine [Moles/time] in 24 hour Urine

162

1.98

3.27

1.2

1.1

0.81

0.70

umol/24h

0.52

(3024891) Influenza virus A+B Ag [Presence] in Specimen

317

2581

1.23

3.27

1.2

1.1

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1639

17766

0.91

3.23

1.7

1.6

—

(3007566) Smooth muscle Ab [Titer] in Serum

326

2671

1.23

3.18

1.3

103.03

142.82

titre

0.41

248

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

130

2.08

3.16

1.1

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

128

927

1.38

3.16

1.2

—

32.14

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

145

1072

1.36

3.15

1.1

—

(3019897) Erythrocyte [DistWidth] in Red Blood Cells by Automated count

1159

0.67

3.14

3.6

2.7

13.37

13.14

0.98

1145

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

3.25

3.13

1.0

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

305

2487

1.23

3.12

1.5

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1384

15091

0.90

3.07

1.3

18.07

10.60

u/ml

0.87

540

5869

(43055514) Macroprolactin [Presence] in Serum or Plasma

233

1.76

2.98

1.3

1.4

—

(3033086) Enterovirus Ab [Titer] in Serum

3.85

2.97

1.1

1.0

—

(3034770) Mitochondria Ab [Titer] in Serum

320

2639

1.22

2.96

1.2

1.3

651.43

957.64

titre

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

141

1.99

2.93

1.0

1.4

37.85

105.97

ng/l

1.59

(3003694) ABO and Rh group [Type] in Blood

2803

26494

1.08

2.93

1.4

1.5

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

4.71

2.91

1.0

1.1

2.85

1.15

mg/l

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

328

1.62

2.84

1.0

1.3

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

401

1.55

2.77

1.2

—

(3013931) Oligosaccharides [Presence] in Urine

8.33

2.75

1.0

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

102

731

1.40

2.73

1.2

1.1

—

(3022145) Colonoscopy Study observation

935

10342

0.89

2.73

1.4

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

125

2.00

2.69

1.2

1.1

—

(3045788) Cell count panel - Pleural fluid

126

938

1.35

2.68

1.4

1.5

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

469

1.50

2.68

1.1

1.2

325.18

328.08

u/l

0.01

426

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

451

3877

1.17

2.66

1.8

1.9

39.30

39.60

u/l

0.10

407

3452

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

2.12

2.63

1.5

1.3

1.18

1.43

iu/ml

0.46

(3007164) IgA [Mass/volume] in Serum or Plasma

2048

19197

1.08

2.63

1.6

1.5

2.34

2.37

g/l

0.26

1260

11871

(3026389) Candida sp identified in Specimen by Organism specific culture

167

1298

1.29

2.63

1.4

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

158

2029

0.77

2.62

1.5

1.6

—

(3044009) aPTT.lupus sensitive (LA screen)

2.30

2.57

1.1

1.2

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

782

8703

0.89

2.55

2.4

2.3

12.52

13.05

nmol/l

0.96

698

7871

(3002256) Pathology report gross observation

1090

11910

0.90

2.54

1.3

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

8066

81931

0.93

2.53

5.2

5.0

5.88

5.92

mmol/l

2.20

7462

75579

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

192

1527

1.26

2.53

1.1

1.2

0.38

1.05

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

323

1.58

2.52

1.9

2.2

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

323

1.58

2.52

1.9

2.2

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

1227

11268

1.10

2.52

1.7

—

(4024509) Urine culture

473

4103

1.16

2.50

2.2

1.9

—

(3010838) Calcium [Moles/time] in 24 hour Urine

192

1530

1.26

2.49

1.7

1.9

4.67

4.92

mmol/24h

0.59

172

1359

(3033099) Centromere Ab [Titer] in Serum

194

1.75

2.49

1.3

1.1

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

224

1.70

2.48

1.7

1.5

0.21

0.32

mmol/l

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

498

0.56

2.48

1.3

1.5

29.53

38.14

nmol/l

0.83

446

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

325

1.57

2.47

1.9

2.2

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

2.67

2.44

1.6

1.5

497.93

500.96

nmol/l

0.01

(3037522) Nuclear Ab [Titer] in Serum

1393

12890

1.09

2.43

1.4

483.64

515.12

titre

0.30

286

2662

(3019174) dRVVT (LA screen)

2.24

2.43

1.1

1.2

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

203

1.73

2.43

2.8

2.7

312.54

209.63

ug/l

0.12

203

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

447

1.48

2.43

1.7

1.9

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

447

1.48

2.43

1.7

1.9

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

447

1.48

2.43

1.7

1.9

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

447

1.48

2.43

1.7

1.9

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

443

0.54

2.43

1.6

1.9

8.29

3.04

u/ml

—

135

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

335

1.55

2.41

1.2

968.75

949.23

titre

0.03

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

699

1.38

2.39

2.1

2.0

2.02

1.47

u/field

0.53

374

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

122

1598

0.76

2.38

1.4

1.5

57.63

59.95

ug/l

0.28

122

1598

(1002224) Polysomnography panel

367

4277

0.85

2.37

1.1

—

(3032641) Amino acids panel - Urine

3.64

2.36

1.1

1.2

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

381

3268

1.17

2.35

2.1

2.3

10.17

10.20

g/l

0.05

326

2920

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

2294

21684

1.07

2.35

1.4

1.79

1.88

u/ml

0.11

611

5806

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

558

1.42

2.35

1.1

0.12

10.23

nmol/l

—

117

(3018738) Hemoglobin F/Hemoglobin.total in Blood

2.04

2.30

3.8

3.4

9.48

3.49

0.80

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

238

1961

1.22

2.30

1.5

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

3.48

2.26

1.1

1.2

—

(3022621) pH of Urine by Test strip

797

7203

1.11

2.26

3.3

2.6

6.25

6.07

4.95

557

4837

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

380

3279

1.16

2.20

2.0

2.4

0.70

0.86

g/l

0.40

318

2824

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

128

989

1.30

2.17

1.1

—

(3016135) IgD [Mass/volume] in Serum

3.68

2.15

1.0

1.2

22.14

31.67

mg/l

—

(3008536) Aspergillus sp Ab [Presence] in Serum

196

1.68

2.14

2.5

2.3

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

250

1.60

2.14

1.4

1.9

30.52

39.82

u/l

0.30

229

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

197

1.68

2.10

1.2

1.1

—

21.56

u/ml

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

156

1946

0.80

2.10

1.1

3.17

2.08

u/ml

0.38

1083

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

103

779

1.32

2.05

1.2

1.3

196.47

194.30

titre

0.01

142

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

325

1.51

2.04

3.1

2.6

0.61

mmol/l

0.05

325

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

247

0.44

2.02

1.3

1.1

17.44

60.39

u/ml

5.64

240

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

270

1.56

2.01

1.2

1.3

27.64

343.42

ug/l

1.51

133

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

282

2395

1.18

2.01

2.1

1.9

—

(3041096) Erythrocytes [Presence] in Urine by Automated

2708

25864

1.06

2.01

4.2

3.3

0.12

0.25

estimate

0.63

918

7899

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

2.50

2.00

1.2

1.5

28.85

29.50

nmol/l

0.01

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.22

2.00

1.2

1.0

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1532

16316

0.93

2.00

1.3

28.89

31.96

iu/ml

0.35

420

4769

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

331

2852

1.17

1.98

1.4

1.3

—

(3012516) Albumin [Mass/volume] in Urine

2738

28591

0.94

1.98

3.5

3.6

57.53

52.27

mg/l

0.60

1881

18694

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

178

1.69

1.97

1.1

1.2

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

115

1474

0.78

1.97

1.2

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

312

2678

1.17

1.97

2.0

2.3

0.01

0.00

g/l

0.46

261

2358

(3020491) Glucose [Moles/volume] in Blood

664

1.34

1.96

1.8

2.0

7.63

6.51

mmol/l

1.95

483

(3020682) Albumin/Creatinine [Ratio] in Urine

2790

29107

0.94

1.95

4.1

4.3

11.60

9.22

mg/mmol

1.46

1841

18580

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

682

6168

1.11

1.95

1.2

91.64

137.65

u/ml

3.27

253

2273

(3008898) HLA-B27 [Presence]

274

3206

0.85

1.93

1.1

—

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

633

1.34

1.90

3.2

3.4

133.19

176.40

nmol/l

0.34

627

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

2.05

1.90

1.0

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

114

1.84

1.86

1.0

0.01

0.48

u/ml

1.09

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

382

1.44

1.86

1.4

2.1

327.40

38447.96

u/ml

—

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

107

1.87

1.85

1.8

1.7

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

2.39

1.84

1.5

1.7

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

612

0.67

1.84

1.0

1.1

1.19

2.04

u/ml

0.34

196

(40761536) Microorganisms panel - Urine sediment

794

7262

1.10

1.84

4.8

4.0

—

(3034426) Prothrombin time (PT)

301

1.50

1.83

1.3

1.2

31.87

28.36

1.77

301

(3001122) Ferritin [Mass/volume] in Serum or Plasma

4529

43975

1.05

1.82

3.4

3.2

137.59

125.31

ug/l

1.64

4205

41185

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

294

1.50

1.81

1.1

—

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

742

6773

1.10

1.79

1.6

1.5

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

184

1524

1.21

1.77

1.2

1.1

7238.22

7069.00

iu/ml

0.01

350

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

701

0.70

1.77

1.1

14.24

18.01

u/ml

0.28

262

(40768806) Pleura Pathology biopsy report

125

993

1.26

1.77

1.4

1.6

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

198

2360

0.84

1.76

1.2

1.1

2.60

2.28

u/ml

0.14

109

1345

(3042111) Morphology [Interpretation] in Bone marrow Narrative

187

1553

1.21

1.75

1.7

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

321

1.47

1.74

1.1

—

(3026657) Rickettsia conorii Ab [Titer] in Serum

3.33

1.74

1.0

1.1

—

371.20

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

202

1691

1.20

1.74

1.8

1.7

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

509

4562

1.12

1.74

2.5

2.4

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

2.92

1.72

1.0

1.3

—

mmol/l

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

364

1.43

1.71

1.1

93.49

94.07

0.04

285

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

179

1487

1.21

1.69

1.5

0.33

0.39

nmol/l

0.63

141

1136

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

195

1.59

1.67

1.3

1.17

mmol/l

0.11

195

(3012920) Ethanol [Mass/volume] in Serum or Plasma

3.16

1.66

1.3

1.4

1.57

2.26

g/l

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

132

1625

0.81

1.65

1.1

3.80

4.38

u/ml

0.14

852

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

289

2506

1.16

1.65

2.0

2.3

0.00

g/l

-0.00

261

2353

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

152

1843

0.82

1.64

1.8

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

118

941

1.26

1.64

1.2

65.67

70.02

u/l

0.20

108

825

(3044927) Protein electrophoresis panel - Urine

109

861

1.27

1.64

1.4

1.1

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

980

9100

1.08

1.64

4.2

4.3

12.60

29.67

ug/l

2.41

796

7417

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

710

6505

1.10

1.61

2.1

2.2

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

319

2792

1.15

1.61

1.9

2.3

0.04

0.03

g/l

0.05

281

2518

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

488

1.35

1.60

1.3

1.9

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

488

1.35

1.60

1.3

1.9

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

9203

91183

1.07

1.59

16.6

12.0

26.10

26.60

u/l

1.29

9026

88618

(3013139) Helicobacter pylori Ag [Presence] in Stool

556

6118

0.90

1.57

1.2

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

716

1.29

1.57

1.7

1.8

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

682

0.72

1.55

1.1

1.2

1.21

8.74

u/ml

1.07

227

(1761482) Bacteria [#/volume] in Urine by Culture

244

2101

1.16

1.55

5.1

4.1

—

(3042631) Mycobacterium sp identified in Specimen

144

1184

1.22

1.53

2.5

2.9

—

(3004451) EKG impression Narrative

509

1.34

1.53

1.3

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

727

0.73

1.53

1.2

1.3

194.86

184.41

pmol/l

0.10

727

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

214

2496

0.85

1.51

2.0

1.9

193.82

205.27

pmol/l

0.88

197

2371

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

2.59

1.51

2.4

2.1

153.87

267.74

ug/l

—

(3032057) Clostridioides difficile [Presence] in Stool

177

1.58

1.50

1.4

1.9

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

104

1297

0.80

1.49

1.1

2.51

3.54

eliau/ml

0.85

584

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

1.90

1.48

1.4

0.16

0.53

iu/ml

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

283

1.45

1.48

1.1

—

3.85

—

(3020961) Endomysium IgA Ab [Titer] in Serum

512

4639

1.11

1.48

1.2

1.1

217.92

177.97

titre

0.14

140

(3035880) pH of Pleural fluid

504

1.33

1.47

1.2

1.3

7.43

7.41

0.50

330

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

133

1091

1.22

1.46

2.6

2.5

29.72

24.80

iu/ml

0.25

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.81

1.46

1.1

1.0

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

1909

18214

1.06

1.46

2.0

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

330

0.60

1.46

1.0

1.2

7.94

14.07

u/ml

—

212

(3008401) Mugwort IgE Ab [Units/volume] in Serum

170

2013

0.84

1.46

1.1

0.73

1.16

u/ml

0.85

997

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

292

3317

0.88

1.45

1.9

47.74

40.66

nmol/l

2.86

286

3229

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

2.37

1.45

1.0

1.5

—

(1617658) Protocol used for examination of sentinel lymph nodes

557

0.70

1.45

1.0

1.1

—

(3017400) Magnesium [Moles/volume] in Urine

2.50

1.45

1.0

1.1

2.63

3.40

mmol/l

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

252

1.47

1.44

1.2

1.1

—

(3026820) Hemoglobin [Mass/volume] in Venous cord blood

3.12

1.43

1.0

183.20

158.69

g/l

—

(40768793) Breast Pathology biopsy report

157

1869

0.84

1.43

1.3

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

9275

91972

1.07

1.43

31.4

20.7

74.52

78.43

umol/l

19.23

9174

90860

(3003888) Timothy IgE Ab [Units/volume] in Serum

176

2073

0.85

1.42

1.1

3.79

5.98

u/ml

1.71

1191

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

1176

0.80

1.41

1.3

6.92

7.23

mmol/l

0.43

1045

(3042951) Complement C1q Ab [Units/volume] in Serum

2.25

1.40

1.0

1.1

—

26.59

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

304

1.42

1.39

1.4

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1183

12539

0.94

1.39

1.5

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

359

3205

1.12

1.38

5.9

1.50

1.48

mg/l

0.22

324

2956

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

1183

0.80

1.37

1.2

1.3

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

123

0.41

1.36

1.0

1.3

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

591

5420

1.10

1.36

2.0

2.1

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

556

1.30

1.34

1.2

140.50

90.82

u/l

1.42

470

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

733

1.26

1.34

1.8

1.5

—

(36660697) Celiac disease serology panel - Serum

831

7738

1.08

1.34

1.2

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

2.14

1.33

1.0

1.2

225.11

292.62

nmol/l

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

541

1.30

1.31

1.4

1.5

6.53

9.20

ug/l

0.90

486

(3027923) C peptide [Moles/volume] in Serum or Plasma

515

1.30

1.6

1.5

1.17

1.24

nmol/l

0.27

380

(3026692) Albumin [Mass/volume] in Peritoneal fluid

242

1.45

1.29

1.3

1.6

12.09

13.35

g/l

0.30

185

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

193

1.50

1.28

1.1

—

(3020874) Milk IgE Ab [Units/volume] in Serum

692

0.75

1.28

1.1

1.2

0.57

2.70

u/ml

2.56

278

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

113

927

1.22

1.28

1.3

1.4

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

279

2466

1.13

1.28

1.9

2.0

12.04

11.79

mg/l

0.20

256

2312

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

361

1.36

1.27

1.1

1.2

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

315

2807

1.13

1.27

1.4

265.14

274.02

ug/g

0.33

190

1651

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

286

2534

1.13

1.26

1.4

1.3

3.96

4.77

u/ml

0.17

228

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

1.79

1.26

2.2

1.8

1.73

1.74

mg/l

—

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

1.79

1.26

2.2

1.7

0.85

0.80

mg/l

—

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

1.79

1.26

2.2

1.7

2.33

1.50

mg/l

—

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

1.79

1.26

2.2

1.7

0.57

0.86

mg/l

—

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

1.79

1.26

2.2

1.7

3.92

1.48

mg/l

—

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

1.79

1.26

2.2

1.7

6.30

3.10

mg/l

—

(37021550) Renin [Units/volume] in Plasma --upright

186

1.51

1.25

1.3

1.4

144.19

106.11

mu/l

0.23

143

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

277

1.41

1.25

1.2

—

(3002523) Influenza virus A Ag [Presence] in Specimen

154

1809

0.85

1.24

1.2

1.1

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

581

1.27

1.24

1.7

1.5

72.49

83.42

umol/l

3.64

581

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

688

1.25

1.23

2.0

1.6

30.70

25.00

u/ml

0.50

133

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

117

1407

0.83

1.23

1.0

1.1

0.17

0.54

u/ml

1.38

509

(3004716) Salmonella sp identified in Stool by Organism specific culture

475

4338

1.10

1.22

1.3

1.4

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

1.90

1.22

1.1

1.2

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

500

4579

1.10

1.21

1.5

27.38

24.72

iu/l

0.95

406

3808

(3027456) Digoxin [Moles/volume] in Serum or Plasma

204

1775

1.15

1.19

3.6

3.2

0.74

0.82

nmol/l

2.94

161

1416

(3036071) Salmonella sp Ab [Titer] in Serum

297

1.38

1.19

1.0

1.1

—

(44806420) Estimation of glomerular filtration rate

962

0.80

1.18

2.4

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

187

1618

1.16

1.18

1.1

—

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

444

1.31

1.18

1.3

1.2

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

2.31

1.18

1.0

—

(3003740) Influenza virus B Ag [Presence] in Specimen

155

1810

0.85

1.18

1.2

1.1

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

541

1.28

1.18

1.2

29.79

25.30

u/l

0.21

449

(3023430) Cat dander IgE Ab [Units/volume] in Serum

130

1539

0.84

1.17

1.1

5.22

5.51

u/ml

0.05

736

(40768446) Kidney Pathology biopsy report

402

1.32

1.16

1.7

1.8

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

1.16

0.0

1.0

—

5.98

—

(3004616) Nuclear Ab [Presence] in Serum

133

1122

1.19

1.15

1.4

1.3

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

241

2128

1.14

1.15

1.4

1.3

2.77

3.46

u/ml

0.19

137

(40765089) Chromosome analysis panel - Blood by G-banded

368

1.33

1.15

1.1

1.0

—

(3025941) Bacteria identified in Stool by Culture

542

5002

1.09

1.13

1.3

1.2

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

326

1.35

1.13

1.3

1.2

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1592

15231

1.05

1.13

1.7

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

305

3387

0.90

1.11

1.6

20.67

15.50

u/ml

0.47

825

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

1.70

1.10

2.2

1.8

1.07

1.00

mg/l

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.78

1.10

1.2

2.34

1.72

umol/24h

0.62

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

432

1.30

1.10

1.3

1.2

—

(3010375) cycloSPORINE [Mass/volume] in Blood

468

1.28

1.09

27.1

28.4

106.04

118.68

ug/l

0.92

383

(3012989) Citrate [Moles/time] in 24 hour Urine

2.38

1.09

2.4

1.4

1.34

2.16

mmol/24h

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

2.38

1.09

1.0

1.5

1.48

3.01

mu/l

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

283

2536

1.12

1.08

1.4

1.3

15.81

8.29

u/ml

0.69

361

(3026493) Urate [Moles/volume] in Serum or Plasma

2316

23931

0.96

1.08

3.0

2.8

326.85

346.15

umol/l

14.37

2010

21214

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

129

1.55

1.05

1.6

2.1

—

(21494434) Karyotype in Bone marrow

804

1.21

1.04

1.2

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

1173

0.83

1.03

1.3

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

815

1.20

1.02

4.7

5.2

211.96

87.08

u/ml

0.60

266

(3034891) Synovial lining cells/cells in Synovial fluid

405

0.71

1.02

1.7

1.5

4.80

3.91

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

439

0.73

1.01

2.1

130.63

166.73

ug/min

—

105

(3017704) Immunofixation for Urine

483

1.26

1.00

1.6

1.5

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

205

1.42

1.00

1.5

1.6

0.30

0.38

ug/l

0.82

136

(3024980) IgG subclass 4 [Mass/volume] in Serum

189

1662

1.14

1.00

1.5

1.6

0.71

0.79

g/l

0.52

145

1311

(3020393) Adenovirus Ag [Presence] in Stool

180

1.44

1.00

1.8

1.6

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1076

10229

1.06

0.98

4.7

4.9

32.55

32.30

0.28

764

6938

(3004446) Plasmodium sp identified in Blood by Light microscopy

1.71

0.98

2.2

2.6

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

2.17

0.98

1.0

1.2

36.48

33.42

umol/24h

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

120

1024

1.17

0.96

1.3

1.4

0.38

0.40

g/l

0.17

739

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

106

1249

0.85

0.95

1.2

1.4

2.62

4.24

ug/l

3.00

1124

(3027135) IgG subclass 1 [Mass/volume] in Serum

120

1025

1.17

0.95

1.3

1.4

6.79

6.63

g/l

0.14

742

(3028192) IgG subclass 2 [Mass/volume] in Serum

120

1025

1.17

0.95

1.3

1.4

2.74

2.89

g/l

0.31

744

(3013166) Neutrophils/Leukocytes in Synovial fluid

233

1.37

0.94

1.4

1.3

56.97

56.16

0.04

194

(4062490) Immunoglobulin typing, IgG

118

1007

1.17

0.94

1.4

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

1.76

0.94

1.0

1.1

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

162

1417

1.14

0.94

2.2

2.40

8.97

titre

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

1.77

0.94

1.1

1.2

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

533

1.24

0.93

1.2

1.08

1.06

ratio

1.08

428

(21494890) Protein electrophoresis panel - 24 hour Urine

108

916

1.18

0.93

1.8

2.0

—

(3001186) Copper [Moles/volume] in Serum or Plasma

268

1.34

0.93

1.1

1.3

16.43

16.57

umol/l

0.07

233

(3017950) Salicylates [Moles/volume] in Serum or Plasma

2.22

0.93

1.2

1.8

—

1873.43

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

185

1635

1.13

0.92

1.1

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.71

0.92

1.2

1.1

16.92

13.81

u/l

0.13

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

184

1.41

0.91

1.3

1.2

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

184

1.41

0.91

1.3

1.2

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

159

1.45

0.90

6.7

7.6

9.86

10.44

0.58

159

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

1.75

0.89

2.3

1.3

—

(4281824) Cell count and differential, peritoneal fluid

850

0.82

0.89

1.3

1.2

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

797

7542

1.06

0.88

1.5

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

266

2410

1.11

0.88

1.9

2.0

2.93

6.21

iu/l

0.78

101

995

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

119

1.51

0.87

1.3

1.2

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

119

1.51

0.87

1.2

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

220

2445

0.90

0.87

1.5

1.4

—

(3009871) Measles virus Ab [Titer] in Serum

357

0.73

0.86

1.9

1.7

2704.00

3151.70

titre

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

594

1.21

0.85

1.7

1.5

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

128

1.48

0.85

1.2

1.0

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

104

1.54

0.84

1.1

1.2

23.34

20.96

u/l

0.17

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

108

927

1.17

0.83

1.3

1.2

24.50

45.13

u/ml

—

(3049717) Cytology report of Urine Cyto stain

368

3398

1.09

0.82

2.3

2.8

—

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

1.87

0.81

1.2

1.00

1.26

u/field

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

197

1.37

0.81

7.1

6.8

71.30

69.97

0.11

152

(40761539) Cells [Type] in Urine sediment by Light microscopy

206

1.36

0.80

1.3

1.2

—

(3000285) Sodium [Moles/volume] in Blood

172

1.40

0.80

1.3

1.2

132.59

138.84

mmol/l

2.78

138

(3036782) Glucose [Moles/volume] in Pleural fluid

108

933

1.16

0.78

1.3

1.4

6.10

6.35

mmol/l

0.50

101

866

(3041918) Cholesterol [Moles/volume] in Pleural fluid

190

1.37

0.78

1.1

1.2

1.77

1.55

mmol/l

0.50

117

(3023487) Leukocytes [#/volume] in Peritoneal fluid

339

1.27

0.78

1.9

2.1

577.80

3078.29

e6/l

0.54

228

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

296

2717

1.09

0.77

1.4

1.3

40.19

35.84

u/ml

0.11

140

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

721

1.18

0.77

1.6

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

128

1122

1.14

0.76

1.3

64.78

54.56

u/ml

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

575

1.20

0.76

1.5

1.4

4.89

4.88

umol/l

0.01

504

(40759836) Histone Ab [Presence] in Serum by Immunoblot

759

1.17

0.76

1.2

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

472

0.78

0.76

8.8

6.2

1416.57

8615.40

u/ml

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

1.70

0.75

1.0

1.8

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

149

1.41

0.75

1.6

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

313

0.73

0.75

1.0

12.86

10.83

u/ml

0.14

205

(3025886) Oxalate [Mass/time] in 24 hour Urine

2.08

0.74

1.4

1.2

16.70

34.20

mg/24h

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

712

0.83

0.74

1.3

1.2

—

(3005322) IgE [Units/volume] in Serum or Plasma

654

6193

1.06

0.74

1.4

1.3

168.34

266.78

u/ml

3.19

601

5783

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

324

1.27

0.74

1.3

1.2

0.31

0.30

g/l

0.27

259

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

106

920

1.15

0.74

1.5

1.3

1.61

1.48

nmol/l

0.52

825

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

425

0.78

0.73

1.2

8.06

9.90

mm/h

0.57

425

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

184

1.36

0.73

1.3

1.2

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

533

1.20

0.72

1.7

1.5

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

112

1274

0.88

0.69

2.1

2.6

5.02

8.07

umol/l

2.56

950

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

5781

57093

1.03

0.69

3.3

3.1

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

776

1.16

0.69

1.4

1.2

58.86

73.35

u/ml

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

536

1.19

0.69

1.5

1.6

6.02

6.38

u/l

0.10

429

(3047007) Chlamydophila sp Ab [Presence] in Serum

123

1389

0.88

0.68

1.3

1.2

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

245

2247

1.09

0.68

1.3

1.4

25.32

52.42

u/ml

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

110

1.45

0.68

2.3

4.7

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

816

1.15

0.67

1.5

1.4

143934.08

122203.74

e6/l

0.14

539

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

0.53

0.66

1.0

1.2

—

39.38

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

743

1.16

0.66

1.1

283.81

285.61

mg/l

0.07

679

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

1.51

0.65

1.0

1.1

0.04

0.03

u/ml

0.58

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

184

1669

1.10

0.65

1.1

8.21

17.36

au/ml

2.86

372

(40762887) Creatinine [Moles/volume] in Blood

1.61

0.65

1.5

1.6

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

1.61

0.65

1.0

1.1

—

(3014051) Protein [Presence] in Urine by Test strip

2669

26108

1.03

0.65

3.4

3.0

0.08

0.07

0.09

608

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

154

1.36

0.64

2.9

3.2

26.35

45.18

mg/l

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

359

1.23

0.63

1.4

1.8

40.25

39.88

g/l

0.16

359

(3018333) Ribosomal P Ab [Presence] in Serum

701

1.16

0.62

1.2

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

1.59

0.61

1.0

1.1

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

1.67

0.61

3.2

5.5

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

217

1.29

0.61

1.8

1.3

22.09

25.42

g/l

0.54

165

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

1.46

0.61

4.1

3.8

1.51

1.35

mg/l

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

1.57

0.60

1.1

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

200

1.30

0.60

1.4

1.1

20.07

20.16

mmol/l

0.03

179

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

629

1.16

0.59

1.2

—

(4212803) Bone marrow aspirate examination

1.50

0.59

1.1

1.0

—

(3038026) Centromere Ab [Units/volume] in Serum

667

1.15

0.59

1.4

1.2

49.03

47.16

u/ml

—

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

1.53

0.59

1.0

2.6

—

79.08

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

491

1.18

0.58

1.2

1.1

23.38

25.36

u/l

0.14

437

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

780

1.14

0.58

1.2

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

1.56

0.58

1.4

1.1

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

744

1.14

0.57

6.0

4.1

51.26

54.59

u/ml

0.06

735

(3000012) Reticulocyte production index

151

1369

1.10

0.57

2.3

2.1

0.99

0.89

1.36

113

907

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

558

1.17

0.56

1.8

1.5

—

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

495

0.83

0.56

3.9

2.4

200.12

199.70

u/l

0.02

488

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

251

2699

0.93

0.56

1.5

1.4

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

1.45

0.56

1.0

1.9

—

(3008691) Amylase [Enzymatic activity/volume] in Peritoneal fluid

1.45

0.56

1.4

1.2

56.38

1384.94

u/l

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

228

2110

1.08

0.55

1.3

1.4

246.27

253.79

u/ml

0.18

139

1284

(3045142) Bone marrow Pathology biopsy report

119

1067

1.12

0.55

1.4

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

1.58

0.54

1.2

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

729

1.14

0.54

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

720

1.14

0.53

1.2

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

348

3279

1.06

0.52

2.1

1.8

—

32.21

—

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

0.62

0.52

1.2

1.0

—

(3001556) Androgen free Index in Serum or Plasma

0.61

0.52

1.2

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

209

1936

1.08

0.51

1.5

1.6

133.51

143.46

au/ml

0.47

595

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

620

1.15

0.51

1.2

—

(3000330) Specific gravity of Urine by Test strip

477

4540

1.05

0.51

4.0

3.4

1.02

ratio

1.16

434

4090

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

508

4844

1.05

0.50

1.1

1.15

8.98

u/ml

0.63

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

553

0.85

0.50

1.4

1.5

—

(3050794) Legionella sp Ab [Presence] in Serum

1.43

0.49

1.1

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

108

0.65

0.48

1.1

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

271

1.22

0.48

1.6

2.7

222.73

116.05

ng/l

0.44

186

(3018851) Theophylline [Moles/volume] in Serum or Plasma

1.45

0.48

1.7

1.6

54.27

45.21

umol/l

0.48

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

166

0.72

0.47

1.1

1.9

1.81

1.95

ug/l

—

(3041806) Other cells [#/volume] in Blood by Manual count

322

0.81

0.47

1.8

1.5

0.47

0.52

e9/l

0.52

322

(3047189) Immunofixation for 24 hour Urine

430

0.84

0.47

1.3

1.7

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

228

2129

1.07

0.47

1.5

1.6

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

871

1.11

0.47

3.4

3.8

—

(3035320) C reactive protein [Mass/volume] in Body fluid

739

1.12

0.46

3.2

2.5

25.13

29.57

mg/l

0.51

527

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

291

1.20

0.46

1.6

1.9

12896.05

13506.21

e6/l

0.02

151

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

492

0.85

0.44

2.2

1.8

19.37

351.91

pmol/l

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

751

1.12

0.44

1.2

—

(40768797) Stomach Pathology biopsy report

1263

12304

1.03

0.44

1.3

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

746

0.88

0.43

1.1

8.86

8.79

iu/ml

0.01

179

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

752

1.12

0.43

1.2

—

(40758358) Immune stain study

1.61

0.43

1.0

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

248

1.21

0.42

1.2

1.3

11.42

13.10

pmol/l

—

105

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

1.43

0.42

3.5

4.8

—

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

0.66

0.42

1.7

1.6

—

(3009677) Dengue virus Ab [Presence] in Serum

1.56

0.42

1.2

1.1

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

184

0.76

0.41

2.1

1.8

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.41

0.0

1.1

—

(3020934) Sesame Seed IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.0

—

9.18

—

(3028714) Urate [Moles/time] in 24 hour Urine

0.00

0.41

0.0

1.2

—

(3029396) Erythrocyte agglutination [Presence] in Blood

240

1.21

0.41

2.9

3.0

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

1025

0.91

0.41

1.9

1.5

55.86

58.84

0.35

654

(3027305) Fractional oxyhemoglobin in Arterial cord blood

0.00

0.40

0.0

1.1

—

37.52

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

0.40

0.0

6.8

—

(3020093) Fractional oxyhemoglobin in Venous cord blood

0.00

0.40

0.0

1.2

—

70.74

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

699

0.89

0.40

1.2

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

1.39

0.40

1.2

1.1

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

0.40

0.0

6.9

—

0.24

—

(3024471) HLA-A [Type]

297

1.18

0.39

1.0

—

(3025130) Human papilloma virus identified in Specimen

114

1239

0.92

0.38

1.7

1.8

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.37

0.38

1.0

1.1

104.73

101.60

titre

0.04

(3000034) Microalbumin [Mass/volume] in Urine

769

0.90

0.38

3.1

3.0

84.36

64.13

mg/l

0.20

576

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

215

2028

1.06

0.36

2.5

2.4

181.81

109.20

ug/min

1.39

122

1233

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

1.36

0.36

1.2

1.3

75.22

114.89

ug/l

—

(3006270) Folate [Moles/volume] in Blood

735

1.10

0.35

1.1

1.2

318.74

361.51

nmol/l

1.21

615

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.43

0.35

1.0

1.1

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

214

2021

1.06

0.35

1.3

59.11

40.89

u/ml

0.62

182

(3007463) Buprenorphine [Presence] in Urine

1.39

0.35

3.0

5.7

—

(3022670) pH of Venous cord blood

1.39

0.35

1.0

1.1

—

(40768443) Skin Pathology biopsy report

426

4095

1.04

0.35

1.2

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1102

11269

0.97

0.34

2.3

2.2

—

(3024932) HLA-DR beta [Type]

292

1.16

0.34

1.1

—

(42528615) Etanercept [Mass/volume] in Serum or Plasma by Immunoassay

1.33

0.33

1.0

1.2

2.63

1.66

mg/l

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

139

1297

1.07

0.33

1.1

1.49

1.50

g/l

0.11

129

1183

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

118

1.27

0.33

1.0

—

(3016244) Insulin [Units/volume] in Serum or Plasma

710

1.10

0.33

2.2

3.4

21.62

25.28

mu/l

0.63

674

(3041672) Baker's yeast Ab [Presence] in Serum

0.70

0.33

1.2

1.1

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

615

1.11

0.33

1.4

113.33

455.10

titre

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

136

1270

1.07

0.32

1.2

25.52

14.11

u/ml

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

262

2498

1.05

0.32

1.3

—

(3025577) Chromium [Mass/volume] in Blood

507

0.89

0.31

2.2

3.75

2.27

ug/l

0.38

422

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

348

0.86

0.31

2.7

3.3

92.71

140.14

au/ml

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

276

1.16

0.31

2.6

3.2

43.75

45.01

0.10

276

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

453

0.88

0.30

4.9

4.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

858

1.08

0.30

1.2

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.30

0.30

6.7

7.4

—

(3009508) Creatinine [Moles/volume] in Urine

3115

31468

0.98

0.30

3.6

7.57

7.77

mmol/l

1.38

2674

26820

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

163

0.80

0.29

1.2

1.1

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

217

0.83

0.29

1.1

1.2

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

109

0.73

0.29

1.1

—

(3014891) Appearance of Pleural fluid

121

1.24

0.28

1.7

1.5

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

545

1.10

0.28

2.5

2.0

102.41

111.42

ng/l

0.34

545

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

151

0.79

0.28

1.1

1.3

73.00

67.11

ug/l

0.14

151

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

121

0.74

0.27

1.0

1.1

6.89

6.64

u/ml

—

121

(4211845) Urine protein measurement

442

1.11

0.26

2.2

3.2

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

199

1899

1.05

0.25

2.5

2.1

0.94

0.82

nmol/l

1.34

162

1619

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

1.25

0.25

4.7

5.3

—

(3028029) Mesothelial cells/Leukocytes in Pleural fluid

148

0.81

0.24

1.1

1.5

5.43

10.34

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

254

0.87

0.23

1.0

1.3

3.45

10.49

u/ml

0.83

183

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

171

1.17

0.23

1.8

2.2

6.08

7.91

mmol/l

2.62

102

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

128

1349

0.95

0.23

1.1

2.06

2.86

0.47

193

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

520

5070

1.03

0.22

1.0

1.1

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

162

1.17

0.22

1.3

1.1

—

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

276

1.12

0.22

5.3

6.4

8.16

8.50

0.11

276

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

0.00

0.21

0.0

1.1

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

0.06

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

0.00

0.21

0.0

1.0

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.21

0.0

1.0

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

180

1876

0.96

0.21

3.3

3.6

831.90

772.49

u/ml

0.03

165

1714

(3006462) Nitrate [Presence] in Urine

401

1.10

0.21

2.2

3.3

—

(3020650) Glucose [Presence] in Urine

304

0.89

0.21

1.1

1.7

0.00

0.02

estimate

0.80

304

(3032868) Hemoglobin electrophoresis panel in Blood

102

0.78

0.21

1.6

1.5

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

103

0.78

0.21

1.1

1.2

5.89

5.81

mmol/l

—

103

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

105

0.76

0.21

3.3

4.6

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

126

1.19

0.21

1.0

1.1

0.28

3.89

u/ml

—

(40760512) CD34 cells/cells in Bone marrow

0.00

0.21

0.0

1.7

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

200

2077

0.96

0.20

1.2

1.3

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

117

1.20

0.20

1.0

1.1

0.57

0.70

u/ml

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

0.00

0.20

0.0

1.1

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

354

3442

1.03

0.20

1.3

1.4

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

340

3304

1.03

0.20

3.1

3.7

156.46

2214.55

u/ml

1.69

299

2850

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

520

1.08

0.19

1.0

1.1

—

(3003329) Lymphocytes/Leukocytes in Synovial fluid

766

0.94

0.18

1.6

1.5

35.74

29.85

0.75

466

(3051101) Glucose [Moles/volume] in Cord blood

143

0.84

0.18

6.3

6.7

8.66

8.31

mmol/l

0.15

143

(3036670) Protein [Mass/volume] in Synovial fluid

270

1.11

0.18

1.4

1.2

42.14

39.42

g/l

0.49

139

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

376

1.09

0.18

1.0

1.1

1.42

8.16

u/ml

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

227

0.88

0.18

1.0

1.1

32.51

38.97

iu/ml

0.26

227

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

261

1.11

0.18

1.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

261

1.11

0.18

1.0

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

261

1.11

0.18

1.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

261

1.11

0.18

1.0

1.1

—

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

7318

73356

0.99

0.18

30.5

19.8

13.63

13.60

0.96

7260

72387

(4146454) Self-monitoring of blood glucose

928

0.95

0.18

2.5

2.7

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

1.17

0.17

1.3

1.6

233.86

318.48

umol/24h

—

(3003327) Ova and parasites identified in Stool by Light microscopy

333

3414

0.97

0.17

1.6

1.7

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

785

1.06

0.17

1.3

1.4

82.17

77.98

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

105

1100

0.95

0.17

1.7

1.5

—

(3042733) HLA Ab [Presence] in Serum

330

1.09

0.16

4.7

4.6

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

381

0.92

0.16

3.1

4.5

9.48

8.84

mg/l

0.22

304

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

836

1.05

0.16

1.2

1.4

—

(3016750) Collection duration of Urine

466

1.07

0.16

2.5

2.3

497.69

494.86

min

0.06

346

(3027901) Hemoglobin [Mass/volume] in Arterial cord blood

1.11

0.16

1.0

165.13

163.85

g/l

—

(40765096) Chromosome analysis panel by Banding

286

0.91

0.15

1.1

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

565

1.06

0.15

1.5

10.80

6.11

u/l

0.66

492

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

150

1.13

0.14

1.8

1.9

3.24

4.07

nmol/l

1.09

144

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

232

2379

0.97

0.14

1.1

4.62

7.35

eliau/ml

0.71

297

(3002619) Bacteria identified in Specimen by Culture

237

1.10

0.13

1.2

—

(3005011) Chlamydia sp Ab [Titer] in Serum

142

1.13

0.12

1.4

1.5

—

(4015189) Microbial culture of sputum

210

0.90

0.12

1.6

2.2

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

701

0.95

0.12

1.3

2.17

3.38

u/ml

0.25

414

(40768795) Lymph node Pathology biopsy report

893

0.96

0.11

1.1

1.2

—

(37208534) Antinuclear antibody arbitrary concentration in serum

322

0.93

0.11

1.0

1.1

—

(3020876) Protein [Mass/time] in 24 hour Urine

122

1182

1.03

0.11

1.8

2.4

1.48

1.31

g/24h

0.32

702

(44806071) Cardiolipin IgM antibody measurement

134

1.12

0.10

1.2

1.1

—

(3019832) Treponema pallidum Ab [Presence] in Serum

962

9702

0.99

0.10

1.7

1.8

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

534

0.95

0.09

1.0

—

(3000475) Leukocytes [#/volume] in Synovial fluid

230

2255

1.02

0.09

1.7

1.6

12064.18

14586.09

e6/l

0.63

160

1575

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

390

1.05

0.08

1.1

—

(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum

0.81

0.08

1.0

23.70

11.82

u/ml

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

764

0.97

0.08

1.2

107.45

107.74

pmol/l

0.01

764

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

1.03

0.07

1.4

2.1

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

225

1.07

0.07

1.9

2.0

0.08

0.19

nmol/l

2.00

167

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

511

1.04

0.07

7.4

7.1

16.31

94.72

ug/l

1.09

334

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

285

0.95

0.06

2.0

1.8

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

366

0.96

0.06

1.0

1.1

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

409

4048

1.01

0.06

3.2

3.6

125.98

64.86

u/ml

0.39

397

3908

(4133840) Spirometry

254

0.94

0.06

1.3

1.2

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

780

0.97

0.06

1.1

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

167

1645

1.01

0.05

1.4

1.3

53.49

33.52

u/l

0.71

149

1427

(40768441) Liver Pathology biopsy report

697

0.97

0.05

1.6

1.5

—

(3034092) Cytoplasmic Ig cells/cells in Blood

110

0.91

0.05

14.6

8.7

0.24

0.20

—

110

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

112

1101

1.02

0.04

1.1

—

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

221

0.95

0.04

1.5

1.3

29.40

39.26

0.84

149

(3051387) C reactive protein [Mass/volume] in Capillary blood

188

1858

1.01

0.04

5.0

3.5

28.43

27.78

mg/l

0.09

133

1297

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

111

1.08

0.04

1.3

1.5

—

(44813793) Dust mix specific IgE antibody measurement

666

1.02

0.03

1.1

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

240

1.04

0.03

6.4

6.9

4.83

5.33

kpa

1.56

240

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

169

0.95

0.03

1.1

1.4

—

(3024263) Appearance of Synovial fluid

451

0.97

0.03

1.5

1.6

—

(43055442) Apixaban [Mass/volume] in Serum or Plasma

161

1.06

0.03

1.5

96.26

120.40

ug/l

0.43

139

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

331

3290

1.01

0.02

1.5

1.4

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

251

1.04

0.02

1.3

1.6

10.96

9.08

ug/l

0.77

251

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1033

10350

1.00

0.02

2.1

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

315

3133

1.01

0.02

1.5

68.37

5.46

iu/ml

0.62

607

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

300

3012

1.00

0.02

1.4

1.3

208.65

226.88

miu/ml

0.35

115

1359

(3027035) Albumin [Mass/time] in 24 hour Urine

1.07

0.02

1.4

1.3

—

526.17

—

(3004775) Volume in Urine collected for unspecified duration

651

1.01

0.01

2.4

2.3

707.82

645.71

0.57

437

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

8191

81844

1.00

0.01

23.0

15.7

86.80

81.95

ml/min/173m2

71.27

7669

75364

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

217

0.97

0.01

1.7

1.3

—

(3048879) Bone marrow aspiration report

223

1.03

0.01

2.0

1.9

—

2.00

—

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

7424

74187

1.00

0.00

33.0

20.5

334.07

332.62

g/l

33.80

7376

73739

(3043410) Blood group antigens tested for on Red Blood Cells

246

0.98

0.00

2.0

1.7

—

(40758292) HTLV I+II Ab panel - Serum

184

1.03

0.00

1.4

1.3

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

132

0.98

0.00

14.2

11.9

4.62

5.65

mmol/l

2.05

132

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

127

1.02

0.00

1.0

1.1

0.14

1.64

u/ml

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

114

0.96

0.00

1.0

1.1

1.21

0.28

u/ml

0.34

114

(3006598) pH of Arterial cord blood

160

1.00

0.00

1.0

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

105

1.05

0.00

1.2

1.1

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

468

1.00

0.00

1.3

—

(3044007) Cell count panel - Peritoneal fluid

297

1.01

0.00

1.6

1.9

—

(3048689) Calprotectin [Mass/mass] in Stool

1233

12324

1.00

0.00

2.3

2.6

161.59

132.28

ug/g

1.31

981

9900

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

0.95

0.00

2.3

3.4

—

(3010937) Rubella virus Ab [Presence] in Serum

0.95

0.00

1.0

1.1

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3025830) Chlamydophila pneumoniae IgM Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

19.20

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

0.86

-0.00

1.2

1.1

—

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

(3000876) Codfish IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3017497) Pine Nut IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

0.04

—

(3001729) Color of Synovial fluid

0.89

-0.00

1.2

1.5

—

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

0.98

-0.00

1.0

4.94

1.89

u/ml

—

(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(3044590) Delta aminolevulinate [Moles/volume] in Urine

0.00

-0.00

0.0

1.0

—

17.57

—

(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(40759632) Porphyrins [Mass/mass] in Stool

0.00

-0.00

0.0

1.2

—

(40761593) Coagulation factor VIII Ab [Presence] in Platelet poor plasma by Immunoassay

0.00

-0.00

0.0

1.4

—

(3010801) 5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

21.00

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

0.87

-0.00

1.8

1.7

—

(3043614) Bacteria identified in Aspirate by Culture

0.00

-0.00

0.0

1.0

—

(3041198) Albumin [Mass/volume] in Peritoneal dialysis fluid

0.00

-0.00

0.0

9.2

—

232.67

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

0.89

-0.00

1.0

1.1

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

0.93

-0.00

1.0

—

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

6.7

—

(3020399) Glucose [Mass/volume] in Urine

0.00

-0.00

0.0

2.2

—

0.07

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

0.92

-0.00

4.0

6.4

—

(3014178) Parietal cell Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

53.56

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

0.88

-0.00

1.3

1.1

0.01

2.92

u/ml

—

(43055189) Lymphocytes [#/area] in Urine sediment by Microscopy high power field

0.00

-0.00

0.0

1.0

—

(3009179) Lactate [Moles/volume] in Peritoneal fluid

0.00

-0.00

0.0

1.0

—

1.82

—

Mortality – FinRegistry

↥

Association

Association between endpoint FE and mortality.

Females

Parameter	HR [95% CI]	p-value
FE	3.467 [3.14, 3.83]	< 0.001
Birth year	0.993 [0.99, 1.0]	0.091

During the follow-up period (1.1.1998 — 31.12.2019), 10372 out of 32811 females with FE died.

Males

Parameter	HR [95% CI]	p-value
FE	3.414 [3.09, 3.78]	< 0.001
Birth year	0.987 [0.98, 1.0]	0.005

During the follow-up period (1.1.1998 — 31.12.2019), 13356 out of 36763 males with FE died.

Mortality risk

Mortality risk for people of age

years, who have FE.

N-year risk	Females	Males
1	0.319%	0.657%
5	2.023%	3.63%
10	4.947%	8.736%
15	8.595%	15.863%
20	15.413%	26.844%

Relationships between endpoints

↥

Index endpoint: FE – Focal epilepsy

GWS hits: 1

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Focal epilepsy

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints